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ABSTRACT 
 
AIM OF STUDY 
 
 To study the clinical profile and outcome in toxin induced acute kidney 
injury. To find out incidence of AKI among poison cases. 
 
MATERIALS AND METHODS 
 In this study we had selected all cases who had developed renal failure 
after toxin ingestion or animal bite (snake, wasp sting and scorpion). In this 
prospective study cases admitted to the Poison Control, Training and Research 
Centre of Government General Hospital, Madras Medical College were 
monitored and evaluated for development of AKI.  
 
RESULTS AND OUTCOME 
 Total number of cases during the study period was 4125. Total number of 
death during the period was 264(6%). Total case presented with renal failure is 
178(4.3%).Total number of cases with dialysis requirement is 130(83%).Total 
number of cases not requiring dialysis was 48 (17%).Total number of males is 
115(64%)Total number of females 63(36%) .Total number of death in AKI IS 
45(17%).most common cause of death is paraquat33% 
 
CONCLUSION 
 Incidence of AKI in our study population was 178 (4.3%) of which 
dialysis requirement was seen in 130 (83%). Snake bite was the leading cause of 
toxin induced AKI (46%). Risk factors for the development of AKI in this 
population include cellulitis, regional lymphadenopathy, presence of fang 
marks, while predictors of poor outcome were hypotension, DIC and 
rhabdomyolysis. Early adequate administration of snake anti-venom had 
reduced the severity of AKI. Type of snake bite particularly pit viper bite had 
very poor outcome. Paraquat and wasp had very high incidence and mortality 
among the study group. 
INTRODUCTION: 
Snake bites, insect stings (animal toxin), chemical poisoning and plant 
poisoning are one of leading causes of AKI among patients presenting at a tertiary-
care hospital in India. 
Although AKI is relatively less prevalent in India than other tropical diseases 
the patients have a mean age of 30 to 40 years, which is young compared with 
patients in developed countries. In a prospective study conducted by Rajenderan et 
al in 2007 among patients admitted in tertiary care toxicology unit nearly 68.75% 
were related to snake bites particularly Russell's viper(1) . 
  Copper sulfate, rat killer, hair dye, indigenous medicine, dichromate etc are 
also swallowed in suicide attempts. Wasp and scorpion stings also were responsible 
renal injury. Snake envenomation is a significant public health problem in India.  
Some practitioners prescribe medicines and herbs contaminated with heavy 
metals, toxic chemicals, pesticides, or poisonous plants picked in error. Delay in 
administering the anti venom and incomplete dosage further increases the risk for 
AKI(2). Similarly, AKI associated with bites and stings has a better prognosis than 
AKI associated with chemical poisoning, 
 
 
 
2 
 
AIM OF STUDY 
o To study the clinical profile and outcome in toxin induced acute 
kidney injury 
o To find out incidence of AKI among poison cases. 
o To do histopathological study in needed cases and its correlation with 
the outcome. 
o To study about correlation of early decontamination and severity of 
renal failure. 
o To follow up the patients and to find out the incidence of CKD in this 
group. 
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REVIEW OF LITERATURE 
SNAKE BITE 
Snake bite is one of the common preventable public health hazard in tropical 
and subtropical countries with dense vegetation and vast tracts of agricultural land. 
India have the highest estimated snake bite mortality in the world (WHO) placing 
the number in between 15,000 to 30,000 per annum. Some experts think that it could 
be between 10,000 to 50000 per annum(2). Discrepancy in data is because of our 
very poor system of entry, reporting of morbidity and mortality and retrieval of 
documents..The most common venomous snakes in India are Indian or spectacled 
cobra, Common krait, Russell's viper, Saw-scaled viper, Hump-nosed pit viper 
White lipped pit viper and sea snake(1,12,13). 
Pathophysiology: More than hundred different types of peptides or proteins, 
lipids, amines, carbohydrates etc. have been isolated from snake venoms, not all of 
which are toxic to humans. Endothelial disruption and activation or inhibition of 
coagulation proteins or platelets, caused by phospholipases, serine proteases, 
disintegrins, metalloproteinases and C-type lectins leads to coagulopathy. 
( 4,12). 
Hemorrhagins causes bleeding by directly injuring the vascular endothelium. 
Hyaluronidase, Hydrolases and peptide cytotoxins contribute to the local tissue 
necrosis. Myotoxic phospholipase A2seen in sea snakes is responsible for 
rhabdomyolysis which can later lead to acute renal failure. Permeability factors 
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(bradykinin like peptide(4), endothelin like toxin, VEGF and natriuretic 
peptides)that increase extravastion of plasma, and effects on cardiac and vascular 
smooth muscle can lead to hypotension without any bleeding manifestations. 
Neurotoxins impair transmission at NMJ by acting either pre synaptically or post 
synaptically. 
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AKI is common after hemotoxic or myotoxic snakes bites.(2) The incidence 
of AKI varies from5% to 29% depending on the species and the severity of 
envenomation.(4,5) The onset of renal failure is from a few hours to as late as 96 h 
after the bite and the duration ranges from 2 to 3 weeks. Prolonged AKI with 
oligoanuria after snake bite is an indication for renal biopsy which usually reveals  
cortical necrosis or acute tubular necrosis associated with interstitial nephritis or 
extracapillary glomerulonephritis(9,10). Clinical recovery from snake-bite-induced 
AKI is usually complete, unless cortical necrosis is present. Mortality in snake-bite-
related AKI ranges from 1% to 20%.(3,11,13). Extremes of age ,female gender, 
hemodynamic instability, DIC, thrombocytopenia, delayed anti-venom treatment, 
native medication, applying tourniquet,and presence of corticalnecrosis are 
associated with poor  prognosis.(13) Although monospecific antivenom 
administration is the strategy of choice since species identification is difficult in 
most of the times polyvalent anti venom specific to India is being  commonly used.If 
AKI is already established, early and frequent peritoneal or hemodialysis is 
lifesaving. Muscular symptoms associated with sea snake are improved by 
hemodialysis. Forced alkaline diuresis,if performed early can prevent AKI in 
patients with myoglobinuria or hemoglobinuria.(21,23) In established AKI, 
administration of sodium bicarbonate or mannitol will be life threatening. 
 AKI is common after bites from hemotoxic or  myotoxic snakes.the 
mechanism involved are Direct toxicity, Hemodynamic changes,Intravascular 
hemolysis,Disseminated intravascular coagulation, Immunologic reaction  and 
Rhabdomyolysis 
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PATHOLOGY 
The most common renal pathology is ATN .The other possible renal pathology 
according to various literature are given below 
 Acute tubular necrosis 
 Acute cortical necrosis 
 Interstitial nephritis 
 Thrombotic microangiopathy 
 Mesangiolysis 
 Vasculitis 
 Glomerulonephritis 
 Renal infarction 
Acute cortical necrosis is the most dreaded histopathological finding as it confers 
very poor renal survival.4. Snake bite is the second common cause of acute cortical 
necrosis in India following obstetric causes.(28) Primary glomerular involvement is 
uncommon. Mesangiolysis is an early and most consistent abnormality associated 
with snake bite envenomation(23).Mild focal and segmental mesangial proliferation 
is common. Severe form of crescentic or diffuse proliferative glomerulonephritis is 
very rare   
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ANTI SNAKE VENOM IN INDIA 
 The ASV is prepared  serum institute of India from hyper immune horses  
against the venoms of the  most commonly encountered poisonous snakes in India. 
Each ml. contains 
Cobra  0.6 mg 
Common-Krait  0.45 mg 
Russell's Viper 0.6 mg 
Saw scaled Viper 0.45 mg 
 
HYMENOPTRA 
 This order is sub divided into aspedia, vespidea, formecedae. Wasp, hornet 
and yellow jacket are members of the vespid subgroup(14). Stings are usually 
associated with only local reactions, rarely anaphylaxis, hemolysis, rhabdomyolysis, 
thrombocytopenia, elevated hepatic serum enzymes, acute renal failure and MODS. 
Onset of symptoms will be within 24 hours or be delayed.(16) Initially they may have 
mild symptoms and develop severe acute clinical manifestation later. Clinicians 
should be aware of possible complications of wasp stings in order to provide early 
detection and proper management.Cardiac involvement is characterized both by a 
ischemia and arrhythmia. Respiratory manifestations included laryngeal edema, 
pulmonary edema and pneumonia. Hematologic involvement included intravascular 
hemolysis, leukocytosis, thrombocytopenia and coagulopathy.4,21-23 Direct toxicity 
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to muscles is considered the main cause of rhabdomyolysis and subsequent 
myoglobinuria may be an important cause of acute kidney injury. A CPK level 
>5,000 U/L is associated with AKI. Acute kidney injury is common and most 
serious complication. Renal damage may be caused by Direct toxin 
nephrotoxicity,Hypotension ,Hemoglobinemia,Myoglobinemia. Renal pathology has 
mainly shown acute tubular necrosis and acute interstitial nephritis.(14,15)  Renal 
recovery in acute interstitial nephritis was much longer than in acute tubular necrosis 
(66.5 versus 35.6 days) and may result in interstitial fibrosis and irreversible renal 
failure(15) Renal biopsy should be done early since AIN will respond dramatically 
to early steroid therapy. Renal tubular acidosis, a rare complication, has also been 
reported(34,35,36). 
SCORPION STING 
Scorpions live in warm dry regions in India. Reports from Bellary, 
Rayalaseema, rural Maharashtra, Pondicherry, madras, and vellore  have 
documented such fatalities in children and adults . Scorpion venoms are complex 
mixtures of amino acids, lipids, mucopolysaccharides,  hyaluronidase,  
5-hydroxytryptamine,histamine phospholipase, and neurotoxic peptides(17,18,19). 
Scorpion venoms stimulate autonomic nervous system by opening sodium channels, 
which leads to hemodynamic alterations.  AKI after scorpion sting has been 
described in association with DIC, hemolysis, bleeding in various organs, and 
cardiovascular complications. 
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PATHOLOGY 
The renal pathological changes observed include renal tubular cell 
degeneration, glomerular basement membrane damage and interstitial 
hemorrhage.(19) Hemolytic uremic syndrome has also been reported after scorpion 
sting. In severe cases, early treatment with antivenom can prevent renal and  
cardiovascular complications. 
INGESTION OF RAW CARP BILE 
The raw bile of carp from the family Cyprinidae contains dependent 
nephrotoxic molecules, including cyprinol(38). The amount of bile ingested varies 
from 15 ml to 30 ml. Symptoms begin as abdominal pain, vomiting and diarrhea 10 
min to 12 h after ingestion; jaundice and AKI follow in 62% and 54% of patients, 
respectively(39,40). AKI develops within 2–48 h of ingestion and for 2–3 weeks. 
Renal pathology shows tubular necrosis. The toxic ingredient is 5 α-cyprinol 
sulphate, a 27-carbon bile salt. Renal and liver biopsies will  show acute tubular 
necrosis and hepatocellular injury (42). It has been postulated that by inhibiting the 
cytochrome c oxidase, toxin  promots calcium influx, and inducing lysosome 
membrane instability.() Acute renal failure accounts for more than 80% of the deaths 
(42). Other manifestations include cardiac complications, hemolysis, convulsion and 
coma (42). Treatment is mainly supportive and  Renal replacement therapy. 
10 
 
PLANT TOXINS 
There are thousands of plants around the world, which are lethal to the 
humans.In india plant toxins that are of renal significance are Cleistanthus collinus, 
Thevetia peruviana (Yellow Oleander) and abrus precatorius. 
THEVETIA PERUVIANA (YELLOW OLEANDER) 
Cardiac glycosides are found in a diverse group of plants including Yellow 
Oleander .The more than 200 naturally occurring cardiac glycosides have been 
identified. Toxin will bind to a site on the cell membrane, producing reversible 
inhibition of the Na+-K+  ATPase. This increases intracellular Na+ and decreases 
intracellular K+. Elevated intracellular Na+ concentrations produce increased 
intracellular calcium concentrations via an Na+ -(Ca++)-exchanger. In response to the 
increased intracellular Ca++ the sarcoplasmic reticulum releases more calcium 
intracellularly, resulting in depolarization of the cell.(43)As a result of this enhanced 
cardiac contractions, which are delayed after depolarization occurs. Cardiac 
glycosides primarily affect cardiovascular, neurologic, and gastrointestinal 
systems.(43) 
CLEISTANTHUS COLLINUS POISONING 
Distal renal tubular acidosis with hyperchloremic normal anion gap 
metabolic acidosis; alkaline urine; and hypokalemia with kaliuresisis the most 
common renal syndrome.[12] A detailed study of renal tubular function revealed 
that the distal tubules are  the most susceptible although proximal tubular injury can 
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occur, and in more severe forms, global tubular dysfunction with diminished 
glomerular filtration rate (GFR) may occur. Metabolic acidosis with defective 
urinary acidification often persists even at discharge. Renal failure is  oliguric in 
most instances and its etiology is probably multifactorial: direct toxin effect 
secondary to hypotension and, possibly, secondary to hypokalemic 
rhabdomyolysis(12). Hyponatremia has also been documented. Hypomagnesemia 
have an additional role in hypokalemia refractory to treatment. 
PARAQUAT POISONING  
 Paraquat   (bipyridilium herbicide) is inactivated by adsorption to clay in the 
soil(44). The toxicity is through redox cycling, leading to generation of superoxide 
anions which react to form hydrogen peroxide and subsequently the highly reactive 
hydroxyl radical(44,45,46). This  is thought to be responsible for lipid peroxidation 
and cell death. A second contributing factor to toxicity is the depletion of (NADPH), 
as both hydrogen peroxide detoxification as well as paraquat redox cycling via 
glutathione is NADPH dependent(44,45,51). The clinical course of paraquat 
poisoning depends upon the amount ingested and the time lag between ingestion to 
hospitalization(early decontamination, extracorporeal therapy, cyclophosphamide 
pulse) .  
Mild poisoning occurs with ingestion of <20 mg of paraquat per kg body 
weight (<1.5 g). In moderate poisoning, ingestion is around 20–40 mg/kg (1.5–3 g). 
Severe poisoning occurs with ingestion of 40–80 mg/kg (3–6 g) .Fulminant 
poisoning is seen after ingestion of more than 80 mg/kg of paraquat (>6 g). After 
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ingestion, maximum concentration is found in the lungs and the concentration peaks 
in 5 – 7 hours . 
 Hemoperfusion (HP) (48,49,51)using activated charcoal if initiated within 4 
hours of paraquat ingestion is thus effective and there is no indication of repeated 
HP . Plasma levels peak early in the course, then decrease rapidly during the first 10 
hours after ingestion because of paraquat distribution to tissues . The clinical course 
of AKI is like oliguric acute tubular necrosis.  
The precipitating factors of renal failure  are multifactorial including delayed 
referal, significant GI fluid losses, circulatory failure, multi-organ failure and 
septicemia. Since > 90% is eliminated by the kidneys as the parent compound, the 
mechanism of AKI is assumed to be related to redox cycling and oxygen toxicity 6 
but this has not been proven. There is no proven antidote for paraquat poisoning. 
Because of free radical  injury is in lungs, some groups advocate routine use of 
antioxidants (Vitamin C 4000 mg/day and Vitamin E 250 mg/day) even though there 
is no data to support.  
Pulse therapy using cyclophosphamide and steriods has been shown to be 
effective in preventing pulmonary fibrosis(51,52). As oxygen potentiates lung 
injury, supplemental oxygen should not be given until  FIO2 falls below 50 . 
Recently there has been some interest in using NO to treat paraquat-poisoning . 
Paraquat specific IgG antibodies and their Fab fragments are effective though the 
“window of opportunity” is very short . Lung transplantation has been performed in 
a few patients. The mortality of paraquat poisoning remains high. MODS with 
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circulatory collapse are associated with 100% mortality in acute stage while late 
onset pulmonary fibrosis with respiratory failure also remains an important cause of 
mortality (49). The survival rate in is around 40 to 50%.  
HAIR DYE POISONING 
 The  major  component  of  hair dye  is (para-phenylenediamine , an aromatic 
amine).(53,54,55) The extent of renal involvement varies from mild transient 
proteinuria to oliguric acute kidney injury.  AKI commonly develops a few days 
after exposure. The mechanisms of kidney injury following hair dye poisoning are 
due to direct toxic effect on kidney It  cause rhabdomyolysis with deposition of 
myoglobin cast within the renal tubules and hemolysis with  hemoglobinuria causing 
ATN(55,56,57).The hypovolemia and hemodynamic instabity (due to direct 
myocardial deppresant activity and cardiac muscle rhabdomyolysis) also predisposes 
to AKI.  The development of AKI in PPD intoxication varies from 47.3% to 100% 
COPPER SULPHATE POISONING 
The incidence of copper sulphate poisoning with  the availability of the 
poison. Its more common in the urban  areas with large number of small scale 
industries like northern parts of Chennai, Thirupur and Thiruvallur districts in 
Tamilnadu. The mortality rates vary from 14-18.8%. In a study from Aligarh in 
1970's, it was the commonest mode of poisonings at that center accounting to 118 
cases over four and a half years.  However, the incidence of copper sulphate 
poisoning is declining in now a days in all parts of India.   It is proposed that free 
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reduced copper binds to sulfhydryl groups and inactivates enzymes such as G6PD 
and glutathione reductase.  
 In addition copper may interact with oxygen species like superoxide anions 
and hydrogen peroxide and catalyze the production of  toxic hydroxyl radicals. 
Lethal dose is about 10-20 g. Renal complications are usually seen on the third or 
the fourth day. In a report of AKI manifestations following copper sulphate 
poisoning, histology of kidney revealed features of acute tubular necrosis in seven 
out of eight kidney biopsies and tubules contained hemoglobin casts. A single case 
of interstitial granuloma was also reported.  
RODENTICIDE POISONING 
Anticoagulant rodenticides are poisons used to kill rats. Main toxins are 
brodifacoum ,Chlorophacinone ,Coumachlor ,Warfarin. The major manifestations of 
this toxin are coagulation dysfunction and liver cell failure.renal failre is very rare 
and is always due to severe hypotension(internal bleeding) or DIC. Rattol containing 
aluminum phosphate is also reported. 
BRAKE OIL POISONING (ETHYLENE GLYCOL) 
Brake fluid is a hydraulic fluid used in most brake applications for the 
vehicles. DOT 3 contains 40% of triethylene glycol monobutryl ether & 30% 
Diethylene glycol monobutryl ether.Once ingested, it is rapidly absorbed from gut. 
DEG is oxidised by alcohol dehydrogenase to 2 Hydroxy ethoxy acetaldehyde & 
then via aldehyde dehydrogenase to 2 hydroxy ethoxy acetic acid (HEAA). The 
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metabolic acidosis and organ dysfunction postulated to result from the generation of 
HEAA.The clinical features of DEG can be divided into 3 phases. First phase 
typically involves GI side effects like nausea, vomiting, abdominal pain and 
diarrhoea. Patient may have abnormal osmolal gap and anion gap metabolic 
acidosis. Second phase occurs 1-3 days following exposure, the hallmark is acute 
renal failure. ATN will be the usual biopsy picture. Multiple other effects reported 
are cardiac dysrhythmias, tachycardia, hypertension pulmonary edema and 
pancreatitis.Third phase occurs 1-2 weeks after the ingestion. Neurological 
complication dominates in this period. Peripheral neuropathy is a common 
occurrence and cranial nerve abnormalities including bilateral facial nerve palsy and 
bulbar palsy have been reported  . Widespread denervation of limb muscles have 
been demonstrated. Patient may become quadriparetic and unresponsive, clinical 
course during this phase is unpredictable. 
CORROSIVE POISONING 
The corrosive poisoning is mostly accidental since it colour mimics water 
and soft drinks. When consumed accidentally the amount consumed will be small in 
quantity due to irritation produced by the corrosives in mouth. If it is consumed with 
suicidal intent( particularly under the influence of alcohol), then amount consumed 
will be high and systemic toxic symptom will develop.AKI after corrosive ingestion 
is not rare but direct damage to the kidney is seen only in severe poisoning. The 
factors that usually causes renal injury are hemodynamic instability, hemolysis, 
rhabdomyolysis, sepsis, severe acidosis and drugs. The risk factors the determine the 
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renal outcome are extremes of ages, amount consumed, time of presentation, type of 
corrosives and MODS. 
MATERIALS AND METHODS 
 In this study we had selected all cases who had developed renal failure after 
toxin ingestion or animal bite (snake, wasp sting and scorpion). In this prospective 
study cases admitted to the Poison Control, Training and Research Centre of 
Government General Hospital, Madras Medical College were monitored and 
evaluated for development of AKI.  
 All the patients included in the study are subjected to Clinical history taking 
and complete physical examination.  
Laboratory investigations included hemoglobin, total and differential 
leukocyte counts, platelet counts, red cell counts, bleeding and clotting time, 
coagulation profile including prothrombin time, activated partial thromboplastin 
time and international normalized ratio (INR), urine microscopy, urine albumin, 
kidney and liver function tests, and serum electrolytes. 
Radiological investigations included X-ray chest and ultrasonography of 
abdomen. All patient were managed according to tamilnadu health system project 
guide lines. Anti snake venom protocol was strictly followed. All patients with 
snake bite was started on ASV as per TNHSP Protocol. 
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INCLUSION CRITERIA 
 All cases of toxin induced AKI (by AKIN criteria)are included in the study. 
EXCLUSION CRITERIA 
 Pre existing renal failure 
 Features suggestive of CKD as per KDIGO definition 
 Chronic NSAID intake 
 Drugs that interact with creatinine   estimation 
 Tablet over dosage 
 Drug induced renal failure 
RESULTS AND OUTCOME 
Total number of cases during the study period was 4125. Total number of 
death during the period was 264(6%). Total case presented with renal failure is 
178(4.3%).Total number of cases with dialysis requirement is 130(83%).Total 
number of cases not requiring dialysis was 48 (17%).Total number of males is 
115(64%)Total number of females 63(36%) .Total number of death in AKI IS 
45(17%).most common cause of death is paraquat33% 
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causes TOTAL AKI 
Snake bite 915 22% 83 46.6% 
Scorpion sting 152 3.5% 3 0.01% 
Unknown bite 244 5.9% 0 0 
Wasp 16 .03% 11 6.1% 
Corrosives 433 10.4% 10 5.3% 
Cuso4 13 .03% 5 2% 
Paraquat 48 1% 27 15% 
Rodenticide 420 10.1% 5 2.8% 
Pesticide 1132 27.4% 15 8.4% 
Plant poison 319 7.7% 9 5% 
Alcohol 71 1.7% 1 0.05% 
Hair dye 39 .5% 7 3.9% 
Others 322 7.8% 2 1% 
Crab bile 1 .001% 1 0.5% 
Total 4125 100% 178(4.3%) 100% 
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Causes TOTAL(M) TOTAL(F) 
Snake bite 54 (65%) 29(35%) 
Wasp 9(82%) 2 (18%) 
Scorpion 1(33%) 2(66%) 
Paraquat 22(82%) 5(8%) 
Hair dye 3 (42%) 4 (58%) 
CuSO4 4 (80%) 1 (20%) 
Insecticide 10 (66%) 5 (34%) 
Corrosive 6 (60%) 4 (40%) 
Plant 3 (34%) 6 (66%) 
Ratkiller 2 (40%) 3(60%) 
DEG 1 (100%) 0 
TOTAL 115 (64%) 63 (36%) 
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causes Dialysis 
requiring(m) 
Dialysis 
requiring 
(f) 
Not 
requiring 
dialysis(m) 
Not 
requiring 
dialysis(f) 
Death 
Snake bite 47 22 8 6 10(16%) 
Wasp 7 2 0 0 2 
Scorpion 0 0 1 2 1 
Paraquat 20 5 0 0 14(33%) 
Hair dye 1 1 2 3 1 
CuSO4 2 0 2 1 1 
Insecticide 6 4 3 2 8(18%) 
Corrosive 3 2 3 2 5( 
Plant 1 1 2 5 1 
Ratkiller 0 3 2 0 2 
DEG 1 0 0 0 0 
Total 90 40 24 24 45 
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MODE OF DIALYSIS 
TYPE HEMODIALYSIS AIPD TOTAL 
DEATH 
death 
  Snake bite 66 3 17 10 
Wasp 9 0 2 2 
Scorpion 0 0 04 1 
Paraquat 22 5 21 14 
Hair dye 2 1 4 1 
CUSO4 1 1 2 1 
Insecticide 4 7 162 8 
Corrosive 1 4 18 5 
Plant 1 1 16 1 
Ratkiller 2 1 18 2 
DEG 1 0 0 0 
TOTAL 109 (83%) 23 (17%) 264 (83%) 45(17%) 
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OUTCOME: 
causes Total cases Partial 
recovery 
Biopsy Death On 
MHD 
Snake bite 83 14 20 10 3 
Wasp 11 1 5 2 1 
Scorpion 3 0 0 1 0 
Paraquat 27 0 0 11 0 
Hair dye 7 0 0 1 0 
CuSO4 5 0 0 1 0 
Insecticide 15 2 0 9 0 
Corrosive 10 0 0 4 0 
Plant 9 0 0 1 0 
Rat killer 5 0 0 1 0 
DEG 1 1 1 0 1 
TOTAL 178 16 27 45 5 
 
SNAKE BITE 
Total number of snake bite admitted was 913,of which 83 had developed 
acute kidney injury and were categorized using AKIN  criteria 69 (83%) patients 
were  received dialysis. Various factors and its impact on dialysis requirement, 
severity of renal failure, outcome are analyzed 
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Residence: On comparison between the rural and urban population regarding the 
outcome was statistically insignificant (P value 0.30). 
Age: On analyzing the age factor, the most commonly affected population was 
between 30 – 50 years. But it was found that progression to CKD and death are more 
in age group more than 50 (P value < 0.05). 
Sex:  On comparison 47 male and 22 females required dialysis and 8 from each 
group doesn’t required dialysis. On detail analysis of the outcome it was found that 5 
patients from each group progressed to CKD whereas 6 male and 4 female patients 
expired. On determining the severity and outcome of the patients by chi-square 
testing (p 0.45) , was found to no statistical significance. 
Time of Bite: 50% of the bite occurred in the early morning from 4am to 8 am and 
32% of bite occurred in the midnight and only 18% of bites were reported during 
day time. Maximum number of death i.e. 50% occurred in the early morning and it 
was statistically significant with P value < 0.05. 
Type of Snakes: On analyzing the data, it was found that all three forms of viper 
bite shows significant statistical effect on both severity of renal of failure( P VALVE 
<0.003 ) and outcome (p.000).this is in concordance with Muthusethupathi et al, and 
Joseph K Joseph et al study. 
Site of bite: 65% of bite occurred in lower limb, 30% of bite occurred in upper limb 
and 5% in trunk. On analyzing the severity and outcome, the site of bite has no 
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statistical significance. But study by Udaya Kumar et al in 2004 showed that bite in 
site with poor vascularity has least toxic. 
Initial care: Of the 11 patients who had native medications 3 has expired and 7 had 
progress to CKD. But on comparing the primary, secondary and tertiary care 
treatment centers there is no significant change in the severity and outcome. This is 
probably due to better health care delivery and proper guideline based management 
protocol (by TNHSP) even at the primary care level itself. 
Delayed Presentation: In a group of Seven patients whose diagnosis was made only 
by the treating physician are all dialysis dependent at presentation (p<0.05), but 
mortality was not statistically significant. 
Time lag for referral: The time lag for referral in dialysis requiring group is 6.6 
hours whereas who doesn’t require dialysis is 5.3 hours. But the time lag for referral 
(according to t test for equality of needs) has no significant effect on severity of 
renal failure and outcome.  
Time lag for ASV:  In dialysis requiring group the mean time lag for initiating ASV 
is 9.94 hours whereas the patient who doesn’t require dialysis the mean time lag if 
7.5 hours. According to test for equality of variance it was statistically significant. 
Dosage of ASV:  63 patients have completed ASV before the onset of renal failure            
(Group A). 20 patients had not completed ASV before the onset of renal failure 
(Group B).  on analysis in group A 11% of patients expired and 14% of patients 
progressed to CKD. In Group B 15% of patients expired and 20% of patients 
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progressed to CKD.On applying chi square test it was found to have statistically 
significant with p value – 0.001.This is in concordance with Muthusethupathi et al, 
and Sitprija et al et al study. 
Time of Completion of ASV: The patients are grouped into 3 categories based on 
completion of ASV , group A < 24 hrs, group B 24 - 48 hours and group C > 48 
hours. Group A consists of 43 patients; Group B consists of 38 patients and 2 
patients in Group C. On statistical analysis there is no significance in dialysis 
requirement and severity of renal failure. But out come (death and progression to 
CKD) for statistically significant in group B and C according to chi square test(p 
valve < .005). 
Cellulitis: Patients were grouped into A and B, with and without cellulites. Group A 
consist of 69 patients of which 80.7% are dialysis dependent where as group B 
consist of 14 patients with 19% dialysis dependent. And regarding the outcome 9 
patients in group A progressed to CKD and 10 expired, Where as in group B only 
one patient progress to CKD and no death reported. On statistical analysis with chi 
square test it was found that severity of renal failure and outcome are statistically 
significant. This observation is concordant with udayakuamr etal 2004 study.  
Cellulitis Total Dialysis Non Recovered Partial Death 
YES 69 57(85%) 12(75%) 50(79%0 9(90%) 10 
NO 14 10(15%) 4(25%) 13(21%) 1(10%) 0 
There is no statistical significance for dialysis requirement  but p < 0.03 for outcome 
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Lymphadenopathy: Lymphadenopathy was present in 46 patients. On statistical 
analysis there was no significance either in the form of severity of renal failure or 
outcome. 
Fang Marks: 23 patients had fang marks and are categoriesed under group A. It was 
found that dialysis requirement in group A was 95.7% when compared to 75% in 
group B. According to Pearson chi square formula it was statistically significant 
with P value of < 0.001. In the same group A 4 patients expired and 4 patients 
progress to CKD when compared to 6 patients in group B and these was also found 
to be statistically significant with P value of < 0.001. So presence of fang mark 
indicates furious and deep bite, which causes maximum envenomation.  
 Total Dialysis Non Recovered Partial Death 
Yes 23 22 1 15 4 4 
No 60 45 15 48 6 6 
P valve  .034    .0005 
On analysis presence of flang marks had significant correlation with  severity and 
out come   
27 
 
DISTRIBUTION OF CASES: 
Age Total DIALYSIS CKD DEATH 
12 -20  2 2 NIL NIL 
21-30  14 12 1 1 
31-40  19 14 NIL 1 
41-50  25 20 3 4 
51-60  15 13 3 4 
ABOVE 60  8 6 3 1 
 
Most of the bites are seen in middle aged men.(30-50).But outcome is severe 
,more deaths and progression to CKD noted in age >50 
RURAL VS URBAN 
PLACE TOTAL DIALYSIS DEATH 
RURAL  60 48 5 
URBAN  23 19 4 
There is not much difference in out come in both group.  
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SEX DIFFERENCE   
Sex Dialysis 
requiring 
Independent Recovered Partial Death 
Male 47(70%) 8(50%) 44(70%) 5(50%) 6(60%) 
Female 20(30%) 8(50%) 19(30%) 5(50%) 4(40%) 
Analysis revealed no statistical significance of sex with dialysis requirement and 
severity of renal failure. 
TIMING OF BITE 
Time Total Dialysis Death 
4 am -8am  42 31 6 (60%) 
8am-6pm  14 14 1 (10%) 
6pm-4 am  27 22 3 (30%) 
Early morning bites has statistical significance in outcome (p<.04) 
TYPE OF SNAKE AND OUTCOME 
There is significance correlation of dialysis requirement with viper bite  
P VALVE <0.003 after eliminating unknown species 
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Type of 
snake 
number Dialysis 
requirement 
Partial 
recovery 
death 
cobra 5(6%) 5 0 1 
krait 4(4.8%) 2 0 0 
Not known 30(36.1%) 25 2 2 
Pit viper 3(3.6%) 3 3 3 
Russell viper  31(37.3) 23 4 4 
Saw scaled 10(12%) 9 4 0 
Analysis shows there is a significant correlation with the type of snake 
SITE OF BITE AND INTENSITY OF RENAL FAILURE 
Site of bite  Total Dialysis CKD Death 
Upperlimb  25 21 4 4 
Lowerlimb  54 42 6 5 
Trunk  3 3 0 1 
No statisticaal significance was found in between the groups 
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OUTCOME IN VARIOUS TREATMENT CENTERS 
First care total Dialysis Death CKD 
Primary  10 8 1 1 
Secondary  41 32 4 3 
tertiary  21 17 2 2 
native  11 10 3 7 
No statistical significance found except for native drug intake   
DELAYED DIAGNOSIS AND OUTCOME 
Diagnosed by  Total Dialysis Death CKD 
SELF  76 60 9 9 
PHYSICIAN  6 7 1 2 
Statistical significance found p valve <.05 
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TIME LAG AND OUTCOME= ANOVA-Time Lag for ASV 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 235.605 2 117.802 2.580 .002 
Within Groups 3653.070 80 45.663   
Total 3888.675 82    
Time lag for ASV is statistically significant association with dialysis dependent 
group 
ASV DOSAGE AND OUTCOME 
COMPLETED 
ASV BEFORE 
TOTAL DIALYSIS DEATH CKD 
YES  63 48 7 9 
NO  20 18 3 4 
Those in whom ASV is completed had a better outcome(p 0.04) 
TIME OF COMPLETION OF ASV AND OUTCOME 
TIME OF COMPLETION OF 
ASV  
TOTAL  DIALYSIS  DEATH  CKD  
<24  43 (52%) 31 (50%) 3(30%)  2 (72%) 
24-48  38 (45%) 34 (47%) 5 (50%) 10 (14%) 
>48  2 (3%) 2 (3%) 2 (20%) 2 (14%) 
There is significant correlation with delayed ASV and renal outcome p valve < .005 
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ANALYSIS OF CLINICAL FACTORS 
MODE OF PRESENTATION 
 Local Hematological Neurological Renal 
Russell 28 12 1 12 
Sawscaled 9 6 0 7 
Pit viper 3 3 0 3 
Cobra 4 0 4 1 
Krait 0 0 4 0 
unknown 28 8 2 9 
 
RENAL FAILURE AT PRESENTATION AND OUTCOME 
Cases death Partial recovery Complete recovery 
32 7 12 13 
 
Of the 83 patients, 32(38%) had renal failure at the time of presentation. In 
these group 7(21%) patients died and 12(37.5%) progress to CKD. On comparing 
these group with remaining 51(62%) patients, those who had renal failure at the time 
of presentation has very poor outcome (P value 0.004). 
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CLINICAL FEATURES AND OUT COME 
 total Dialysis 
dependency 
death Complete Partial 
Edema 72 60 10 51 11 
Lymph node      
Subconjuctival 
bleed 
15 15 4 3 8 
Spontaneous 
bleed 
4 4 2 0 2 
Breathlessness 20 19 5 11 4 
Uremic 
symptoms 
12 12 5 0 7 
Oliguria 22 22 5 9 8 
 
Presence of uremic symptoms: Of that 83 patients, 12(14.5%) patients had 
uremic symptoms at the time of presentation. All of them were dialysis dependent,  
5 patients were expired and 7 patients progress to CKD.  
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LAB PARAMETERS AND OUTCOME 
Parameters Total Dialysis Complete Partial Death 
Hematuria 13 13 2 7 4 
Proteinuria 9 9 3 1 5 
Anemia 19 17 6 8 5 
Thrombocytopenia 9 9 1 4 4 
Fragmented RBC 9 9 1 3 6 
PT /APTT 43 41 22 11 8 
U.MYOGLOBULIN 8 8 1 4 3 
 
Proteinuria  :Of the 83 patients, 9(10%)had proteinuria at the time of presentation. 
All of them were dialysis dependent, 5 patients were expired and 2 patients progress 
to CKD. 
Thrombocytopenia:Of the 83 patients, 9(10.5%) had thrombocytopenia at the time 
of presentation. All of them were dialysis dependent, 4 patients were expired and 4  
progressed  to CKD, 2 patients was diagnosed to have thrombotic micro angiopathy 
in biopsy. 
Fragmented RBC:Of the 83 patients, 9(10.5%) had fragmented RBC. All of them 
were dialysis dependent, 6 patients were expired and 3 patients progress to CKD, 2 
patients was diagnosed to have thrombotic micro angiopathy in biopsy. 
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Subconjunctival  haemorrhage : Of the 83 patients, 15(18%) had subconjectival 
haemorrhage during the course of illness. These patients were dialysis dependent 
and 4 patients expired and 8 patients progress to CKD. On comparing these group 
with remaining 68(82%) patients, those who had suconjunctival haemorrhage at the 
time of presentation has very poor outcome.(P < 0.04) 
Spontaneous bleeding :Spontaneous bleeding was noted in 4 out of 83 patients, of 
which two had expired and two progressed to CKD. All the 4 had signs of DIC. So 
the presence severe hematological manifestation has significant role in renal 
outcome.  
Prolonged PT, APTT:Of the 83 patients, 43(51%) had prolonged PT, APTT. 41 of 
them were dialysis dependent, 8(80%) patients were expired and 11(78%) patients 
progress to CKD. 
Urine myoglobulin  :Of the 83 patients, 8(10%) had urine myoglobulin. All of them 
were dialysis dependent: 3 patients were expired and 4 patients progress to CKD. 
Whole Blood Clotting time : 
WBCT Total Dialysis Non Recovered Partial Death 
<12 30 23(35%) 7(44%) 27(43%) 2(20%) 1(10%) 
12-24 25 18(27%) 7(44%) 19(30% 2(20%) 4(40%) 
24-36 18 16(24%) 2(12%) 12(19%) 5(40%) 1(10%) 
>36 10 10(14%) 0 5(8%) 5(40%) 4(40%) 
P   <0.05    <0.05 
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By using the chi square test in whole blood time normalization has high statistical 
significance in association with outcome and recovery p value < 0.004.  
RENAL PRESENTATION AND DIALYSIS REQUIREMENT 
 AKIN I AKIN II AKIN III 
YES 1 3 63 
NO 3 12 1 
 
Parameter Dialysis requiring Not requiring  
dialysis 
Presenting sr.cr 2.0377 2.0325 
Peak sr.cr 7.3 2.3 
Range 9.3 -0.6 0.7 -3.4 
Hypercatabolic 27 0 
Mean time for renal failure 35.5 43.5 
Mean time for ASV completion 27.5 23.5 
Death 10 Nil 
 
As mentioned in the above table, mean presenting serum creatinie is almost 
same. But peak value is 7.3 for dialysis dependent group. All the cases of hyper 
catabolic aki are dialysis dependent. Mean time of onset of renal failure is much 
earlier in the first group and was found to be statisticaly significant. Mean time for 
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completion of ASV was more or same and has significant difference. All the death 
has been reported only in the dialysis requiring group. Twenty patients underwent 
renal biopsy and fourteen patients had only partial recovery with three patients 
became dialysis dependent(on MHD). 
HYPERCATABOLIC AKI: 27(32.5%) patients had satisfied the criteria for hyper 
catabolic AKI. Of which 16 are male and 11 are female. And following were some 
important features associated with this form of AKI .Totally 9(30%) patients 
received native treatment (statistically significant). 10 cases are due to Russell viper, 
5 due to saw scaled, 3 due to pit viper and 1 due to cobra and remaining 8 species 
not known.  
Mean time of presentation: Day1 - 8 , Day2 - 17 and Day3- one 
patients.ASV was not completed in 21(77%) patients. Cellulitis was present in 
25(92%) patients. Lymphadnopathy was present in 17(62%) of patients .Fang marks 
are present in 9(34%) of patients. 
Renal failure at the time of presentation in 13(50%) of patients. Urine 
showed myogloblin in 7 (25%) of patients. Jaundice was present in 9(34%) of 
patients. DIC was reported in 11(42%) of 27 patients. 
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Type HISTOLOGY OUTCOME(eGFR) FOLLOW UP 
Saw scaled ATN Recovered Recovered 
Saw scaled ACN 82 CKD 3 
Sawscaled ATN 72 CKD3 
Sawscaled ACN 86 CKD4 
Sawscaled ATIN 76 CKD3 
Sawscaled ATN 45 ON MHD 
Rusell ATN Recovered Recovered 
Rusell ACN 60 CKD4 
Rusell ACN 56 CKD3 
Rusell TMA 72 EXPIRED 
Rusell TMA Expired Expired 
Not known ATN 25 ON MHD 
Notknown ATN 45 ON MHD 
Not known ACN 82 CKD4 
Notknown ATIN Expired Expired 
Not known ACN 78 CKD 3 
Not known ATIN Recovered Recovered 
Not known ATN Recovered Recovered 
Not known ATN Recovered Recovered 
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Twenty patients underwent renal biopsy and fourteen patients had only 
partial recovery with three patients became dialysis dependent (on MHD).In the 
biopsy there is no specific correlation with type of snake bite, except for two cases 
of TMA in Russell viper. Other histological features in biopsy are  
ATN; of the eight cases (40%)   reported, four case had been recovered. 
One case became CKD 3A, three other remain dialysis dependent. But no death was 
reported. 
ATIN: Three cases had been   reported and steroid was started. Of the three 
one patient died of sepsis (steroid was withdrawn due to CRBSI), one became 
CKD3A and one completely recovered. 
TMA: Both case expired after becoming dialysis dependent. 
ACUTE CORTICAL NECROSIS: Six cases have been reported. Four of 
them with patchy cortical necrosis and two had focal necrosis. All six had became 
dialysis independent. At last follow up three were in   CKD stage 4 and three were  
in stage 3A.  
Death: Total death observed is ten (12.5%).Cause of death includes DIC in 
4(40%), sepsis 5(50%), VAP 2(20%). Type of snake is pit viper in 3 patients, 
Russell in 4 patients, Not known in one and cobra in one. The result was statistically 
significant by chi-square analysis. 
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PARAQUAT 
Total numbers of cases are 27.More common in middle age men. The most 
common age group is 2nd  and 3rd  decade .Male is to female ratio is 5:1.19(70%) 
patients are illiterate and 12(44%) patients are under the influence of alcohol. 
Among the individual who consumed under influence of alcohol 9(65%) 
expired, and was found to be statistically significant (P<0.04) .Average time to 
initial presentation is 4 hours (range 1-88 hours) . 
Pre emptive dialysis was done in 10 patients .Average time lag to pre 
emptive dialysis is 22 hours .But presumptive hemodialysis had no statistical 
significance ,this indicates delayed presentation and need for hemofiltration. The 
consumption of paraquat was detected by the attenders in 12 cases (for which the 
average period of delay was 19 hours) .This delay in diagnosis led to mortality in 75 
% of this group.  
On multivariate analysis time lag for diagnosis, time lag for hemodialysis 
and presence of anemia has no statistical significance. 
We had categorized the patient into four groups based on the  
amount consumed(Group A >50ml,Group B 50-30ml,GroupcC 30-10ml,and Group 
D<10ml ). 
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Parameters >50ml (A) 50-30ml (B) 30-10ml (C) <10 ml(D) 
Number 6 7 11 3 
Alcohol 5 4 5 0 
Time lag hrs 2 2.3 3 6 
Total lag (HD) 21 22 33 19 
Preemptive 4 3 3 3 
Hb >9 6 5 7 2 
Sr.cr (p) 2.68 2.59 2.86 1.7 
Total hd 3.5 6.5 3 2 
Duration 3.4 5 5 3 
ARDS 5 4 5 0 
PD 2 2 1 0 
Death 6 5 3 0 
Hepatitis 4 3 4 0 
Cardiac inv. 0 1 1 0 
Mean time  death 4.23 5.4 5.5 0 
 
In GROUP A(6) ,presenting  mean serumcreatinine is 2.68,total patients 
given HD is 3 and PD in 3(50%). Average session of HD required is 3.5,for mean 
period of 3.4 days. Multi organ involvement is seen in 4(66%) and ARDS in 
5(83.3%).Death occurred invariably in all patient with mean time 4 days.  
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In GROUP B(7) ,presenting  mean sr. creatinine is 2.3,total patients given 
HD is 5 and PD in 2 (33%). Average session of HD required is 6.5,for a mean period 
of 5 days.Multi organ involvement is seen in 3(40%) and ARDS in 4(57%).Death 
occurred in 5(71%) with a mean time of 5.4 days.  
In GROUP C(11) ,presenting  mean sr.creatinine is 2.86,total patients given 
HD is 9 and PD in 2 (22%). Average session of HD required is 3,for a mean period 
of 5 days. Multi organ involvement is seen in 4(35%) and ARDS in 5(45%).Death 
occurred in 3(27%) with a mean time of 5.5 days. 
In GROUP D(3) ,presenting  mean sr.creatinine is 1.7 ,total patients given 
HD is 2 and PD in 2 (22%). Average session of HD required is 2,for a mean period 
of 3 days with no Multi organ involvement, ARDS or Death. On analysis it was 
found that amount consumed is the most important factor for multi organ 
involvement, renal failure (p valve is <.003)and death (p valve is <.003) 
Preeumptive hemodialysis has not proven to be significant role. By chi square 
analysis hemogloglin <9 had statistically significant outcome 
HYMENOPTERA BITES 
Total cases reported is 16, and 11 (%) presented with AKI. On which 9(81%) 
patients are male and 2(19%) are female. Mean age of presentation is 42.9.More 
common in lower socioeconomic group Number of stings ranges from 34 -88 but on 
analysis by t test number of stings has no impact on outcome Sex has significant 
effect on outcome p<0.45.Two patients received native medication and was found to 
be statistically significant. (p valve of 0.001,which is highly significant).  
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Plasma HB was detectable in 2 patients and by statistical analysis pearson 
chi-square test p valve is<0.001.Average referral lag in patient who died is 15.5 
when compared to 5.5 hrs in remaining and  has definite statistical significance p 
valve <.005 by levene’s test for equality of variance. 
 Rhabdomyolysis was seen in82% of patients, Total number of FAD given 
was 11.Mean peak sr.cr is 7.6.Indication for hemodialysis was 6 with 
rhabhdomyolysis,3 with acidosis, 3 with both. Totally nine(82%) required  
hemodialysis. Average session is 10 (ranges 2-30)and  average duration is 18 days 
(2-33). 
Two patients died one due to rhabdomyolysis  and next patient (defaulted on 
steroids) acidosis .Of the 9 patients with rhabdomyolysis, 2 patients developed 
ATN,2 developed AIN and two died. Of the eleven patients 6(57%) patients 
presented with hyper catabolic AKI.Proteinuria was in all 2 patients with ATIN. 
Biopsy was done in 4 patients 
BIOPSY ATN ATN/AIN AIN 
MALE 1(myoglobulin pigment) 1 1 
FEMALE  1  
 
(Steroids was given in 3   patients with AIN, 2 recovered and one last follow 
up and became CKD ).The intensity of renal failure is much severe (renal failure 
requiring dialysis), particularly for prolonged period. And early biopsy is always 
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needed in suspicion of AIN, which is curable with steroids. Cause of death in most 
occasions will be due anaphylaxis, rhabdomyolysis and renal failure 
Plasma HB and Outcome 
Plasma HB total recovered Death 
YES 2 0 2 
NO 9 9 0 
P value   <0.001 
 
SCORPION 
 TOTAL DIALYSIS DEATH CAUSE 
MALE 1 NO 0 NIL 
FEMALE 2 NO 1 CARDIOGENIC 
SHOCK 
 
In our study period we 152 cases admitted with scorpion sting ,but only 3 
had renal failure. none of the three required dialysis . Average peak sr.cretinine 
2.1All three cases belong to AKIN II Death was noted in 17 year old girl with 
autonomic imbalance. 
HAIR DYE POISONING 
Total patients with poisoning is 39.Total males are 3 and female are 4.Mean 
age of presentation 26.Total number of AKI is 7.FAD done in six cases. Dialysis 
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requiring renal failure is in two cases.Rhabdhomyolysis seen in 6 cases. Since 
toxicity depends on amount consumed we had grouped the patients into three  
Group A : (Those who had consumed >50 ml) Only one patient in this group 
who presented with angioedema, rhabdomyolysis,  peak s.cretinine of 6.7,evidence 
of hemolysis died on day of admission. 
Group B : (Those who had consumed 25-50 ml.) Total 3 patients were in this 
group all 3 presented with rhabdomyolysis, mean peak creatinine2.9.one patient 
received hemolysis and the other two received FAD. 
Group C: (Those who had consumed 25-50 ml.) Total 3 patients were in this 
group all 3 presented with rhabdomyolysis, mean peak creatinine1.7 .All three 
received FAD. 
COPPER SULPHATE POISONING 
PARAMETER MALE FEMALE 
NUMBER 3 2 
FAD 2 1 
HD 0 1 
PD 1 0 
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Cause of AKI Hemolysis Hemodynamic Not known 
Recovered  1 0 2 
Death 1 1 0 
 One patient died of arrhythmia and one died due hemodynamic instability 
RAT KILLER POISONING 
TYPE MALE FEMALE 
RATTOL 1 2 
COMARIN DERIVATIVE 1 0 
ZINC PHOSPHIDE 0 1 
 
TYPE HD PD 
RATTOL 2 0 
COMARIN DERIVATIVE 0 0 
ZINC PHOSPHIDE 0 1 
Both female with rattol poisoning was expired due to fulminant hepatitis 
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PLANT POISONING 
TYPE MALE FEMALE DIALYSIS NOT 
NEEDED 
DEATH 
OLEANDER 2 1 1 1 0 
ODUVNTHALAI 1 5 1(PD) 5 1 
 
Parameters Oleander Oduvanthalai 
Number 3 6 
Mean age 24 26 
Mean peak creatinine 1.9 2.2 
PD  1 
HD 1 0 
Recovered 3 5 
Death 0 1 severe hyperkalemia 
 
INSECTICIDE 
Total number of AKI is 15 and total death is eight. All the eight patients who 
died are ventilator dependent and six of them had hemodynamic instability 
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DAYS OF ONSET 
OF AKI 
HD PD DEATH IN HD DEATH IN PD 
<7 3 1 1 1 
7-14 1 3 1 3 
>14 0 2 0 2 
 
 Male Female HD PD DEATH On 
ventilator 
Hemodynamic 
OPC 4 3 2 4 4 5 4 
Cell oil 0 1 1 0 1 1 1 
Karate 1 1 0 1 1 1 1 
Craine 
killer 
1 0 0 0 0 0 0 
Carbamate 1 0 0 0 0 0 0 
Quinophos 1 0 1 0 1 1 0 
Unknown 1 1 0 1 1 0 1 
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CORROSIVE POISONING 
SEX NUMBER HD PD NON 
DIALYSIS 
DEATH 
MALE 6 1 2 3 3 
FEMALE 4 0 2 2 2 
 
Indication for dialysis is severe acidosis in 4 patients and anuria in one 
patient. Cause of death was sepsis and hemodynamic instability 
 
 
50 
 
DISCUSSION 
Total Number of poisoning cases admitted in our unit during the study period 
was 4125.Total number of acute kidney injury according to AKIN classification is 
178 (4.3%).Of them males are 115(64%) and females are 63(36%). Number of cases 
that required dialysis was 130 of which 21(17%) received Acute intermittent 
peritoneal dialysis due to hemodynamic instability and the remaining received HD 
(83%). 
Renal biopsy was done in 20 patients with snake bite who are dialysis 
dependent for more than fourteen days, 5 patients with wasp sting, one patient with 
crab fish bile and one with brake oil poisoning.  
Total number of death due to poisoning is 131, of which death in toxin 
induced AKI was 23 (17%).On comparisons with study conducted by the same 
institute in 2007-2009 where 32 cases developed ARF. 24 were due to snake bite, 
the rest due to chemical poisons.  
SNAKE BITE 
Total number of snake bite admitted was 913, of which 83(9%) had 
developed acute kidney injury and were categorized with AKIN criteria, 69 (83%) 
patients received dialysis. Among the toxin induced AKI incidence of snake bite 
induced AKI is 46.6%.  
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Various factors and its impact on dialysis requirement, severity of renal 
failure, outcomes were analyzed. On comparison between the rural and urban 
population regarding the outcome was statistically insignificant (P value 0.30). 
On analyzing the age factor, the most commonly affected population was 
between 30 – 50 years. But it was found that progression to CKD and death are more 
in age group more than 50 (P value < 0.05) as was observed  by Attappan et al. 
  On determining the severity and outcome of the patients by chi-square test 
(p 0.45), was found to be of no statistical significance. As stated by Muthusethupathi 
et al increased incidence in males is due to increased exposure 
 50% of the bites occurred in the early morning from 4Am to 10 Am and 32% 
of bites occurred in the midnight and only 18% of bites were reported during day 
time. Maximum number of deaths i.e. 50% occurred in the early morning and it was 
statistically significant with P value < 0.05.Patil TB et al showed incidence during 
early morning and during farm working hours.  
On analyzing the data, it was found that all three forms of viper bite shows 
significant statistical effect on both severity of renal of failure( P  <0.003 ) and 
outcome (p.000) and this is in concordance with Muthusethupathi et al, and Joseph 
K Joseph et al study. Incidence is more with Russell viper and mortality more in pit 
viper 
     65% of bite occurred in lower limb, 30% of bite occurred in upper limb and 
5% in trunk. On analyzing the severity and outcome, the site of bite has no statistical 
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significance. But study by Udaya kumar et al in 2004 showed that bite at site with 
poor vascularity has least toxic. 
On comparing the primary, secondary and tertiary care treatment centers 
there is no significant change in the severity and outcome. This is probably due to 
better health care delivery and proper guideline based management protocol (by 
TNHSP) even at the primary care level itself. 
 The time lag for referral in dialysis requiring group was 6.6 hours whereas 
who did not require dialysis was 5.3 hours. But the time lag for referral (according to 
t test for equality of needs) has no significant effect on severity of renal failure and 
outcome. But earlier studies by Attappan et al and Patil et al showed statistical 
significance. This may be due to proper primary care and early referral  
Time lag for administration of ASV according to test for equality of variance 
was statistically significant with severity of renal failure and outcome. Those who 
completed ASV before the onset of renal failure was found to have statistically 
significant with p value – 0.001.This is in concordance with Udayakumar et al, and 
Sitprija et al et al study.On statistical analysis there is no significance in dialysis 
requirement and severity of renal failure in those who completed ASV after 24 hrs. 
But out come(death and progression to CKD) was statistically significant . 
It was found that severity of renal failure and outcome are statistically 
significant in those with cellulites as observed by Udayakuamr etal 2004 study. In 
our study presence of lymph adenopathy has no significance either in the form of 
severity of renal failure or outcome. But according to Attappan et al regional 
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lymphadenopthy was another significant independent factor for ARF. Just as 
cellulites, regional lymphadenopthy can be a clinical indicator of the amount of 
toxin released by the snakebite.   
 Presence of fang mark indicate furious and deep bite, which causes 
maximum envenomation  and was highly significant with relation to dialysis 
requirement, progression to CKD and death. Those who had renal failure and uremic 
symptoms at the time of presentation had very poor outcome. 
Those who had proteinuria, hematuria, anemia, and thrombocytopenia are 
associated with poor outcome. Patients  who had signs of  DIC were associated with 
viper bites and  presence of DIC is an important factor prognosticating factor as 
stated by Muthusethupathy et al, Joseph K Joseph et al and Attapan et al. In our 
study, 4 patients developed bleeding, which was less than that in other reports. All 
the 4 had signs of DIC. So the presence of   severe hematological manifestations had 
significant role in renal outcome. Spontaneous bleeding was noted in 4 out of 83 
patients, of which two had expired and two progressed to CKD. According to 
Muthusethupathi et al hemorrhage is the major symptom of systemic viper 
poisoning,Persistent bleeding from fang  wounds, venepuncture sites . 
In our study 43(51%) had prolonged PT, APTT. 41 of them were dialysis 
dependent, 8(80%) patients expired and 11(78%) patients progress to CKD. Of the 
83 patients, 8(10%) had myoglobulinuria. All of them were dialysis dependent: 3 
patients expired and 4 patients progressed to CKD. Whole blood time normalization 
has high statistical significance in association with outcome and recovery p value < 
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0.004.those with early normalization of WBCT was associated with reduced dialysis 
requirement and improved outcome  
.27(32.5%) patients had satisfied the criteria for hyper catabolic AKI. Of 
which 16 are male and 11 are female. They are mostly observed in viper bite, native 
medication intake, patient with cellulitis, lymphadenopathy, flang marks. Most of 
them had renal failure at the time of presentation and associated with DIC.  
  On analyzing the renal parameters the is not much difference in presenting 
serum creatinine, but the average peak  sr.creatinine, mean time for onset of renal 
failure, and the mean time for completion of ASV were  significantly high. 
 On analyzing the histopathology there was no specific correlation with type 
of snake bite, except for two cases of TMA in Russell viper. ATN accounts for Eight 
cases (40%) ,ATIN  in three cases(15%) ,TMA in two cases(10%),cortical necrosis 
in Six cases(30%) .Total death observed is ten (12.5%).cause of death includes DIC 
in 4(40%), sepsis 5(50%), VAP 2(20%).Type of snake is pit viper in 3 patients, 
Russell in 4 patients, Not known in one and cobra in one. The result was statistically 
significant by chi-square analysis.  
According to Patil TB et al mortality of snake bite-induced acute renal 
failure is found to be 15.5% in this study. Kalantri et al reported an overall mortality 
of 11% in venomous snake bite patients. In our study mortality is (12.5%) 
 
 
55 
 
PARAQUAT 
The most common age group is 2nd  and 3rd  decade .Male is to female ratio 
is 5:1.Among the individual who consumed under influence of alcohol 9(65%) 
expired, and was found to be statistically significant (P<0.04) . 
Average time to initial presentation is 4 hours (range 1-88 hours) .Pre 
emptive dialysis was done in 10 patients .Average time lag to pre emptive dialysis is 
22 hours .But presumptive hemodialysis had no statistical significance ,this indicates 
delayed presentation and need for hemofiltration. The delay in diagnosis led to 
mortality in 75 % of this group.  
On multivariate analysis time lag for diagnosis, time lag for hemodialysis 
and presence of anemia has no statistical significance in outcome. Total number of 
death is 14(55%),in that 11 have consumed more than 50 ml. 
On analysis it was found that amount consumed is the most important factor 
for multi organ involvement ,renal failure (p valve is <.003)and death (p valve is 
<.003).This results are well supported by study done by JS Sandhu et al,who showed 
that severity of poisoning, late referral and MODS showed increased mortality. 
HYMENOPTERA BITES 
Total cases reported is 16, and 11 (%) presented with AKI. On which 9(81%) 
patients are male and 2(19%) are female. As it was mentioned in previous studies 
Mejia Velez et al, though hymenoptera is a rare cause of animal   bite ,it causes 
higher percentage of AKI .Mean age of presentation is 42.9.  
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Number of stings ranges from 34 -88 but on analysis by t test number of 
stings has no impact on outcome. Sex has significant effect on outcome 
p<0.45.Plasma HB was detectable in 2 patients and by statistical analysis pearson 
chi-square test p valve s<0.001.Average referral lag in patient who died is 15.5 when 
compared to 5.5 hrs in remaining and  has definite statistical significance p valve 
<.005 by levene’s test for equality of variance.  
Rhabdomyolysis was seen in82% of patients in our study, which is supported 
by Zhang ling, Tang yi et al study. Mean peak sr.cr is 7.6.Totally nine(82%) 
required hemodialysis for an average duration is 18 days (2-33). The intensity of 
renal failure is much severe renal failure requiring dialysis, particularly for 
prolonged period as evidenced by sitprija et al. 
Early biopsy was done in 4 patients ,1 patient had ATN with myoglobin 
pigments,1 with  ATN with AIN, and 1 developed AIN .Steroids was given in 3 
AIN, 2  recovered and one last follow up and became CKD .Early biopsy is always 
needed in suspicion of AIN, which is curable with steroids supported by. 
 Two patients died one due to rhabdomyolysis and next patient (defaulted on 
steroids) acidosis. Cause of death in most occasions will be due anaphylaxis, 
rhabdomyolysis and renal failure supported by Zhang ling, Tang Yiet al study 
SCORPION 
Scorpion bite is very common in Tamilnadu. But the incidence of AKI 
scorpion bite rarely reported .in our study period we 152 cases admitted with 
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scorpoin sting , but only 3 had renal failure. None of the three required dialysis . 
Average peak sr.cretinine 2.1and all  three cases belong to AKIN II .Death was 
noted in 17 year old girl with autonomic imbalance. 
HAIR DYE (SUPERVASMOL) POISONING 
Total patients with poisoning is 39 of whom AKI was seen in  7(18%).Total 
males are 3 and female are 4.Mean age of presentation was 26yrs.Dialysis requiring 
renal failure is seen in two cases and Rhabdomyolysis seen in 6 cases. Since toxicity 
depends on amount consumed we had grouped the patients into three, of which 
Patient who had consumed >50 ml was presented with angioedema, 
rhabdomyolysis, evidence of hemolysis died on day of admission .Since the same 
size is too small, statistical analysis is not done. In a  retrospective study which 
included 81 consecutive patients of self poisoning with Supervasmol 33 ®, who 
SVIMS, Tirupati, between May 2008 and April 2010. suggest that the ingestion of 
more than 50ml of the dye was associated with significant rhabdomyolysis and acute 
renal failure, which required haemodialysis.  
COPPER SULPHATE POISONING 
The trend of these poisoning is coming done ,probably due to reduced 
availability. 
Total 13 case were received in the study period and total no. of AKI was 
5(40%). 
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One female patient was dialysis depedent and one male patient received peritoneal 
dialysis both the two patient had evidence of hemolysis. One patient died of 
arrhythmia and one died due hemodynamic instability.In a study done by chug et al 
eleven out of a series of twenty-nine patients (37-9%) with acute copper sulphate 
poisoning developed acute renal failure. Intravascular haemolysis appeared to be the 
chief factor responsible for renal lesions in these patients. 
RAT KILLER POISONING 
Only five cases reported with AKI, 3 patients affected by rattol(aluminium 
phosphide),one with warfarin derivative and one with zinc phosphide. Three patients 
required dialysis and one was given AIPD. Both female with rattol poisoning was 
expired due to fulminant hepatitis. 
PLANT POISONING 
Total nine cases are reported of which six where due to oduvanthalai and 
three due to oleander. Four patients received AIPD and one oduvanthalai required 
dialysis. Renal failure in all cases of oleander is due to cardiogenic shock where as  
oduvanthalai has direct nephrotoxic effect .one patient with oduvanthalai expired 
due to refractory hyperkalemia.In a study conducted by CMC Vellore ,it was  
postulated that  renal failure, oliguric in most instances, has been documented across 
clinical studies, though its etiology is probably multifactorial: direct toxin effect 
secondary to hypotension and, possibly, secondary to hypokalemic rhabdomyolysis. 
 
59 
 
INSECTICIDE 
Total number of AKI is 15 and total death is eight. HD was given in 4 
patients and AIPD was done in six patients with hemodynamic instability. All the 
eight patients who died are ventilator dependent and six of them had hemodynamic 
instability. 
CORROSIVE POISONING 
Total ten patients presented with renal failure. Indication for dialysis is 
severe acidosis in 4 patients and anuria in one patient. Four patients received AIPD 
and one received hemodialysis.Six patients were expired because of sepsis and 
hemodynamic instability. According to Vivek et al corrosive induced renal failure is 
usually due to secondary effect  
BRAKE OIL POSONING 
 One patient had who had consumed brake oil presented with clinical features 
like abdominal pain, vomiting, acute tubular necrosis, pancreatic injury, 
quadriparesis and transient VIII nerve involvement which improved during 
discharge. 
CRAB BILE POISONING 
One case was reported with ingestion of crab bile. He presented with dialysis 
dependent renal failure and was diagnosed as ATIN. 
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CONCLUSION 
 Incidence of AKI in our study population was 178 (4.3%) of which dialysis 
requirement was seen in 130 (83%). 
 Snake bite was the leading cause of toxin induced AKI (46%). 
 Risk factors for the development of AKI in this population include cellulitis, 
regional lymphadenopathy, presence of fang marks, while predictors of poor 
outcome were hypotension, DIC and rhabdomyolysis. 
 Early adequate administration of snake anti-venom had reduced the severity 
of AKI. 
 Type of snake bite particularly pit viper bite had very poor outcome. 
 Paraquat and wasp had very high incidence and mortality among the study 
group. 
 Amount of paraquat consumed was a poor prognostic factor. 
 Preemptive hemodialysis was found to be ineffective in our study 
population. 
  In acute interstitial nephritis   due to wasp, timely and appropriate   
management usually cures the patient without any residual damage. 
 Insecticide, corrosive although high in number had a very low incidence of 
AKI but highly fatal due to associated multi organ involvement. 
 Single case of brake oil poison was observed and presented as biopsy proven 
AIN 
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MASTER CHART 
name age 
AGE 
CODE sex place education timing 
place 
of bite 
site 
of 
bite type of snake 
first 
visit native 
diagnosed 
by  
physician 
TIME LAG  
FOR 
 REFERRAL 
time lag  
for  ASV 
MOHAN 33 3 1 1 2 1 1 4 NOT KNOWN 3 NO SELF 3 3 
VACHITHANATHAM 38 3 1 1 1 1 1 4 PIT VIPER 2 NO SELF 6 8 
SUDAKAR 24 2 1 1 2 1 1 4 RUSELL 3 NO SELF 4 5 
MANI 32 3 2 1 1 1 2 4 RUSELL 3 NO SELF 3 4 
PERUMAL 45 4 1 1 1 3 1 4 SAW SCALLED 1 NO SELF 4 5 
POOVARAGAVAN 42 4 1 1 1 3 1 4 COBRA 2   SELF 2 3 
PALANI 40 4 1 1 2 3 1 4 NOT KNOWN 3 NO PHYSICIAN 12 12 
MOORTHI 48 4 1 1 2 1 1 4 NOT KNOWN 2 NO SELF 2 2 
KANAGAMAL 54 5 2 2 1 1 2 2 PIT VIPER 4 
LOCAL 
APPILICATI
ON SELF 4 9 
NATARAJAN 42 4 1 2 1 2 1 4 KRAIT 2   SELF 3 3 
NAGARAJAN 60 6 1 1 1 3 3 2 NOT KNOWN 2 NO SELF 2 24 
SWARAJKUMAR 45 4 1 2 3 3 3 4 RUSELL 1 NO SELF 3 21 
POVARASI 28 2 2 1 1 1 2 2 SAW SCALLED 2 NO SELF 3 12 
SHANKAR 20 2 1 1 1 1 1 4 RUSELL 4 
ORAL 
DRUGS SELF 14 15 
111 64 6 2 1 1 1 1 4 SAW SCALLED 4 
ORAL 
DRUGS SELF 16 19 
PARASURAM 38 3 1 1 1 2 1 2 RUSELL 2 NO SELF 6 8 
AMBROSE 44 4 1 1 1 3 1 4 NOT KNOWN 2 NO SELF 4 4 
SAKUNTHALA 52 5 2 1 2 1 1 2 RUSELL 2 NO SELF 6 6 
DEVENDRAN 47 4 1 1 1 1 1 4 RUSELL 2 NO SELF 4 6 
ANBALAGAN 43 4 1 1 2 3 1 2 RUSELL 4 
ORAL 
DRUGS SELF 25 26 
SUBRAMANI 37 3 1 1 2 1 1 4 COBRA 2 NO SELF 5 6 
RAJI 45 4 1 1 3 1 1 4 RUSELL 2 NO SELF 3 5 
SARAVANAN 21 2 1 1 1 2 1 4 KRAIT 2 NO SELF 5 6 
ULAGANATHAN 50 5 1 1 1 3 1 4 RUSELL 1 NO SELF 1 1 
PATCHAIAMMAL 35 3 2 1 1 3 1 4 RUSELL 1 NO SELF 2 3 
LAKSHMI 42 4 2 2 1 3 2 2 PIT VIPER 3 NO SELF 6 7 
KAMATHCHI 45 4 2 1 1 1 1 2 NOT KNOWN 2 NO PHYSICIAN 16 17 
MUNNA 30 3 2 2 3 3 2 2 NOT KNOWN 2 NO SELF 4 4 
DEVARAJ 43 4 1 2 1 1 2 3 RUSELL 1 NO SELF 3 21 
PANDIAN 50 5 1 2 2 3 2 2 RUSELL 2 NO SELF 6 8 
KAMATHCI 60 6 2 1 1 1 3 2 SAW SCALLED 3 NO SELF 3 4 
MANJULA DEVI 20 2 2 1 3 2 3 2 NOT KNOWN 4 
ORAL 
DRUGS SELF 18 20 
TAMINA 15 1 1 2 3 2 3 4 NOT KNOWN 2 NO SELF 4 4 
SUBRAMANI 59 6 2 1 2 3 1 4 SAW SCALLED 4 
ORAL 
DRUGS SELF 14 15 
SENGAIYA 77 7 1 1 2 1 1 4 NOT KNOWN 1 NO SELF 3 4 
JAYARAMAN 28 2 1 1 1 1 3 4 NOT KNOWN 2 NO SELF 7 8 
RAJAMMAL 45 4 2 1 1 1 3 4 RUSELL 4 
ORAL 
DRUGS SELF 3 14 
KANIYAMMAL 50 5 1 2 1 1 2 4 NOT KNOWN 2 NO SELF 6 8 
VARALAXMI 45 4 2 2 1 1 2 4 RUSELL 3 NO SELF 4 5 
SUDHAKAR 37 3 1 2 1 1 2 4 RUSELL 2 NO SELF 4 5 
PATCHAIAMMAL 33 3 2 1 1 3 1 3 SAW SCALLED 2 NO SELF 4 5 
VASNTHAMMAL 65 6 2 1 1 3 1 3 SAW SCALLED 4 
ORAL 
DRUGS SELF 23 25 
SUBRAMANI 44 4 1 1 1 1 1 2 RUSELL 3 NO SELF 4 5 
SARAVANAN 33 3 2 1 1 1 1 2 NOT KNOWN 2 NO YES 9 10 
SAROJAMMAL 55 5 2 1 2 1 1 2 NOT KNOWN 2 NO PHYSICIAN 4 4 
SELVAM 35 3 1 1 2 2 3 2 RUSELL 2 NO SELF 1 12 
SARAVANAN 34 3 1 1 2 2 3 4 RUSELL 2 NO SELF 6 8 
KAVITHA 23 2 2 1 2 1 1 4 RUSELL 3 NO SELF 1 2 
KUMAR 32 3 1 1 2 3 1 2 NOT KNOWN 2 NO SELF 4 4 
DANALAKSMI 25 2 2 1 1 3 1 4 NOT KNOWN 2 NO PHYSICIAN 4 4 
JEYARAMAN 56 5 1 1 1 2 1 2 NOT KNOWN 2 NO PHYSICIAN 16 24 
MNUSWAMY 16 1 1 1 1 1 1 4 NOT KNOWN 3 NO SELF 3 3 
RAJI 33 3 2 2 1 1 2 2 RUSELL 3 NO SELF 6 6 
SUNDARAM 24 2 1 2 2 2 2 4 SAW SCALLED 1 NO SELF 4 5 
SEKAR 47 4 1 2 2 3 2 2 RUSELL 2 NO SELF 12 12 
SELVAM 50 5 1 2 2 3 2 4 COBRA 2 NO SELF 3 3 
SALAMMAL 55 5 1 2 1 2 3 4 COBRA 3 NO SELF 5 5 
SIVASHANKAR 45 4 2 1 1 1 1 4 KRAIT 2 NO SELF 1 2 
PARIMALA 40 4 2 1 3 1 1 4 RUSELL 2 NO SELF 2 12 
PALANI 24 2 1 1 2 1 1 4 NOT KNOWN 2 NO SELF 4 4 
MANIVANNAN 33 3 1 1 3 2 1 4 NOT KNOWN 3 NO SELF 4 4 
NAGAMMAL 54 5 2 2 1 3 2 4 NOT KNOWN 3 NO SELF 3 3 
KUPPAN 57 5 1 1 1 3 1 4 RUSELL 1 NO SELF 4 5 
KANDASWMY 45 4 1 1 1 1 1 2 RUSELL 1 NO SELF 2 6 
VARADHARAJAN 34 3 1 1 2 1 1 4 SAW SCALLED 2 NO SELF 3 12 
MAHENDRAN 40 4 1 2 3 1 1 4 RUSELL 2 NO SELF 3 21 
RAJAN 24 2 1 1 3 3 1 4 NOT KNOWN 3 NO PHYSICIAN 24 26 
NAGARAJAN 40 4 1 2 3 3 1 2 COBRA 4 
TOURNIQU
ET SELF 22 22 
SHANKAR 24 2 1 1 3 2 1 2 RUSELL 2 NO SELF 4 5 
KAMATHCHI 29 2 1 1 1 2 3 4 NOT KNOWN 4 
ORAL 
DRUGS SELF 14 16 
NAGARAJAN 60 6 1 1 2 3 3 4 NOT KNOWN 3 NO SELF 14 18 
MANAVALAN 54 5 2 2 1 1 2 4 RUSELL 1 NO SELF 5 6 
VIJAY 45 4 1 2 1 1 2 4 KRAIT 2 
ORAL 
DRUGS SELF 16 20 
pounammal 60 6 2 1 1 3 1 2 NOT KNOWN 2 NO PHYSICIAN 6 9 
THIRUPAL 56 5 1 1 1 3 1 4 RUSELL 4 NO SELF 11 12 
MUNUSWAMY 57 5 1 1 1 1 2 2 RUSELL 2 NO SELF 6 8 
MUNIAPPAN 40 4 1 1 1 1 1 4 NOT KNOWN 3 NO SELF 11 18 
THANSAIMARY 38 3 2 2 2 2 2 4 NOT KNOWN 2 NO SELF 1 24 
JAYA 30 3 2 2 3 3 3 4 NOT KNOWN 2 NO SELF 6 7 
ULAGANATHAN 50 5 1 1 1 1 1 1 SAW SCALLED 3 NO SELF 3 4 
rajesh 28 2 1 1 3 1 3 4 RUSELL 3 NO SELF 2 8 
VAJRAVEL 36 3 1 1 3 1 3 4 NOT KNOWN 3 NO SELF 3 8 
NEDUCHEZIAN 44 4 1 1 1 1 1 4 NOT KNOWN 3 NO SELF 5 9 
 
 
 
 
 completed 
time of  
completion 
TIME OF  
COMPLETION 
asv 
/renal  
failure dose edema 
lymph 
node subconj 
FLANG  
MARKS 
spon. 
bleeding HYPOTENSION breathlessnees neurological uremia oliguria 
NO 26 2 NOT 8 YES YES NO NO NO NO NO NO NO NO 
NO 30 2 NOT 13 YES YES YES YES NO NO YES NO YES YES 
YES 22 1 YES 18 NO NO NO NO NO NO NO NO NO NO 
YES 21 1 YES 18 NO NO NO NO NO NO NO NO NO NO 
YES 23 1 YES 18 YES YES YES NO NO NO YES NO YES YES 
YES 15 1 YES 23 YES NO NO NO NO NO YES YES NO NO 
NO 30 2 NOT 0 YES YES YES YES NO NO NO NO NO YES 
YES 20 1 NOT 13 YES NO NO NO NO NO NO NO NO NO 
YES 26 2 NOT 8 YES NO YES YES YES HYPOTENSION NO NO YES ANURIC 
YES 20 1 NOT 23 NO NO NO NO NO NO YES YES NO NO 
YES 20 1 YES 18 YES YES NO YES NO NO NO NO NO NO 
YES 24 1 YES 13 YES YES NO NO NO NO NO NO NO NO 
YES 34 2 NOT 5 YES YES YES NO NO NO NO NO NO NO 
NO NO NO NOT 13 YES YES YES YES YES NO YES YES YES YES 
YES 38 2 NOT 13 YES YES YES NO NO NO NO NO YES NO 
NO 28 2 NOT 13 YES NO NO NO NO NO NO NO NO NO 
YES 22 1 YES 18 YES YES NO NO NO NO NO NO NO NO 
YES 24 1 YES 18 YES NO NO NO NO NO NO NO NO NO 
YES 15 1 YES 23 YES NO NO NO NO NO NO NO NO NO 
NO 54 3 NOT 23 YES YES NO NO NO NO YES YES YES YES 
YES 17 1 YES 23 NO NO NO NO NO NO NO YES NO NO 
YES 21 1 NOT 18 YES YES NO NO NO NO NO NO NO NO 
YES 14 1 NOT 23 NO NO NO NO NO NO NO YES NO NO 
YES 19 1 YES 18 YES NO NO NO NO NO NO NO NO NO 
YES 20 1 NOT 13 YES YES NO NO NO NO NO NO NO NO 
YES 30 2 YES 13 YES NO YES NO NO NO NO NO NO NO 
NO 37 2 NOT 13 YES YES NO NO NO NO YES NO NO NO 
YES 22 1 YES 18 YES YES NO YES NO NO NO NO NO NO 
YES 24 1 YES 13 NO NO NO NO NO NO NO NO NO OLIGURIC 
NO 28 2 NOT 13 YES NO NO YES NO NO NO NO NO NO 
YES 22 1 YES 18 YES NO NO NO NO NO NO NO NO NO 
YES 43 2 NOT 23 YES YES YES YES YES NO YES NO YES ANURIC 
YES 22 1 YES 18 YES YES NO YES NO NO NO NO NO NO 
YES 32 2 NOT 13 YES NO NO NO NO NO NO NO NO NO 
YES 21 1 NOT 13 YES YES NO YES NO NO NO NO NO YES 
YES 25 2 YES 18 YES YES NO NO NO NO NO NO NO NO 
YES 34 2 NOT 5 YES YES YES YES NO NO NO NO NO NO 
YES 26 2 NOT 13 YES NO NO NO YES NO NO NO NO NO 
YES 22 1 NOT 13 YES YES NO NO NO NO NO NO NO NO 
YES 22 1 YES 18 YES YES NO NO NO NO NO NO NO NO 
YES 24 1 YES 18 MILD NO NO NO NO NO NO NO NO NO 
YES 41 2 NOT 18 NO NO NO NO NO NO YES NO NO OLIGURIC 
YES 22 1 YES 18 YES YES NO NO NO NO NO NO NO NO 
YES 27 2 NOT 13 YES YES NO NO NO NO NO NO NO NO 
YES 22 1 YES 18 YES YES NO NO NO NO NO NO NO NO 
NO 30 2 NOT 13 YES NO NO NO NO NO NO NO NO NO 
NO 28 2 NOT 13 YES NO NO YES NO NO NO NO NO NO 
YES 20 1 YES 18 YES YES NO NO NO NO NO YES NO   
YES 22 1 YES 18 YES YES NO YES NO NO NO NO NO NO 
YES 22 1 YES 18 YES YES NO YES NO NO NO NO NO NO 
YES 47 2 NOT 5 YES YES NO NO NO NO YES YES NO NO 
NO 26 2 NOT 8 MILD NO NO NO NO NO NO NO NO NO 
YES 24 1 YES 13 YES YES NO NO NO NO NO NO NO NO 
YES 23 1 YES 18 YES YES NO NO NO NO YES NO YES YES 
NO 30 2 NOT 0 YES YES YES YES NO NO NO NO NO YES 
YES 16 1 YES 23 YES NO NO NO NO NO YES YES NO NO 
YES 14 1 YES 23 YES NO NO NO NO NO YES YES NO NO 
NO 19 1 NOT 18 NO NO NO NO NO NO NO YES NO NO 
YES 40 2 NOT 18 YES YES NO NO NO NO NO NO NO NO 
YES 22 1 YES 18 YES YES NO NO NO NO NO NO NO NO 
YES 22 1 YES 18 YES YES NO YES NO NO NO NO NO NO 
NO 26 2 NOT 8 MILD NO NO NO NO NO NO NO NO NO 
YES 23 1 YES 18 YES YES NO YES NO NO YES YES YES YES 
YES 22 1 NOT 18 YES YES YES NO NO NO YES NO NO YES 
YES 34 2 NOT 5 YES YES YES NO NO NO NO NO NO NO 
YES 24 1 YES 13 NO NO NO NO NO NO NO NO NO OLIGURIC 
SELF 42 2 NOT 8 YES NO NO NO NO NO NO NO NO NO 
NO 40 2 NOT 13 YES NO NO NO NO NO NO YES NO NO 
YES 23 1 YES 18 YES YES NO NO NO NO YES NO YES YES 
YES 36 2 NOT 18 NO NO YES YES YES NO YES NO YES ANURIC 
NO 36 2 NOT 8 YES NO NO NO NO NO YES NO NO YES 
YES 23 1 YES 18 YES YES NO YES NO YES NO NO YES YES 
NO 38 2 NOT 13 NO NO NO NO NO NO YES YES NO NO 
YES 30 2 YES 18 YES YES NO NO NO NO NO NO NO NO 
YES 32 2 NOT 18 YES NO YES NO NO NO NO NO NO YES 
NO 28 2 NOT 13 YES NO NO NO NO NO NO NO NO NO 
NO 36 2 NOT 8 YES NO NO NO NO NO YES NO NO YES 
NO 19 1 NOT 18 YES YES NO YES NO NO NO NO NO YES 
YES 26 2 NOT 13 YES YES NO NO NO NO NO NO NO NO 
YES 22 1 YES 18 YES NO NO NO NO NO NO NO NO NO 
YES 26 2 NOT 13 YES YES NO YES NO NO NO NO NO NO 
YES 33 2 NOT 13 YES YES NO YES NO NO NO YES NO NO 
YES 34 2 NOT 13 YES YES NO YES NO NO NO YES NO NO 
 
 anuria presentation URINE RBC anemia TCP PT aPTT WBCT 
WBCT  
NORMAL 
BY 
AGMENTED  
RBC 
1ST 
CREATININE AKIN 
SR.CR AT  
INITIATION PEAK 
BUN AT  
RESENTATION 
NO LH NO NO NO NO PROLONGED PROLONGED 20 2 NO 1.4 3 3.4 3.4 78 
NO LR NO NO NO NO PROLONGED PROLONGED 23 2 NO 3.1 3 4.5 6.7 122 
NO H NO NO NO NO PROLONGED PROLONGED 18 2 NO 1.1 2 2.1 2.1 88 
NO LH NO NO YES NO PROLONGED PROLONGED 21 2 NO 1 2 1.6 1.9 86 
NO LHR NO NO NO NO PROLONGED PROLONGED 39 4 NO 3.6 3 3.6 6.1 102 
NO LN NO NO NO NO NO NO NO 1 NO 1.2 3 3.1 3.7 97 
NO LHR NO NO NO NO PROLONGED PROLONGED 14 2 NO 3.4 3 3.4 5.7 67 
NO LH NO NO NO NO NO NO 20 2 NO 0.9 2 1.8 1.8 72 
ANURIC LHR NO YES YES YES PROLONGED PROLONGED 22 2 YES 9.3 3 9.3 9.3 163 
NO N NO NO NO NO NO NO NO 1 NO 1.1 3 3.1 4.1 77 
NO L NO NO NO NO NO NO NO 1 NO 0.9 2 1.9 2 102 
NO LR NO NO NO NO PROLONGED PROLONGED 18 2 NO 2.3 3 3.4 4.4 102 
NO LHR TRACE YES YES NO PROLONGED PROLONGED 26 3 NO 2.3 3 3.9 7.1 88 
ANURIC LHNR NO YES YES YES PROLONGED PROLONGED PRONGED 4 YES 6.7 3 6.7 6.7 99 
NO LHR NO YES YES NO PROLONGED PROLONGED 36 3 NO 2.1 3 3.9 6.6 98 
NO LH NO NO NO NO NO NO NO 1 NO 1.1 3 3.2 5.6 66 
NO L NO NO NO NO NO NO NO 1 NO 1.1 1 1.5 1.9 78 
NO L NO NO NO NO NO NO NO 1 NO 0.7 2 1.5 1.5 71 
NO LH NO NO NO NO PROLONGED PROLONGED PRONGED 4 NO 0.9 3 3.1 4.6 103 
ANURIC LHNR NO NO NO NO PROLONGED PROLONGED PRONGED 4 YES 3.4 3   7.9 88 
NO N NO NO NO NO NO NO NO 1 NO 1.2 3 3.2 4.1 77 
NO LH NO NO NO NO PROLONGED PROLONGED PRONGED 4 YES 1.2 3 2.9 6.1 56 
NO N NO NO NO NO NO NO NO 1 NO 1.1 3 2.1 3.9 56 
NO L NO NO NO NO NO NO NO 1 NO 0.6 3 2 2.4 132 
NO L NO NO NO NO NO NO NO 1 NO 1.1 2 2.2 2.6 121 
ANURIC LHR NO YES YES YES PROLONGED PROLONGED 40 4 YES 1.3 3 3.4 5.6 88 
NO L NO NO NO NO NO NO 18 2 NO 1.9 2 1.9 5.4 66 
NO L NO NO NO NO NO NO NO 1 NO 1.3 3 3.5 4.9 78 
NO HR NO NO NO NO PROLONGED PROLONGED 18 2 NO 2.3 3 3.4 4.4 102 
NO L NO NO NO NO NO NO NO 1 NO 1.1 3 3.2 5.6 66 
NO LR NO NO NO NO NO NO NO 1 NO 2.9 3 3 6.5 84 
ANURIC HR NO YES YES YES PROLONGED PROLONGED 36 3 YES 2.8 3 5.9 8 98 
NO L NO NO NO NO NO NO NO 1 NO 1.3 3 3.5 4.9 78 
NO L NO NO NO NO NO NO NO 1 NO 1.1 2 2.3 3 132 
NO LHR NO NO YES NO PROLONGED PROLONGED 34 3 NO 1 3 3.7 3.9 109 
NO L NO NO NO NO NO NO 25 3 NO 1.1 2 1.9 2.5 89 
NO LHR SUBNEPH. YES YES YES PROLONGED PROLONGED 28 3 YES 3.4 3 3.4 6.9 74 
NO LH SUBNEPH. YES YES YES PROLONGED PROLONGED 28 3 YES 1.5 3 4.2 7.1 66 
NO L NO NO NO NO NO NO 22 2 NO 0.9 2 1.9 1.9 67 
NO L NO NO NO NO NO NO 22 2 NO 0.9 2 1.8 1.9 63 
NO L NO NO NO NO NO NO NO 1 NO 1.6 3 3.1 4.2 73 
NO HR NO NO YES NO PROLONGED PROLONGED 34 3 NO 3.9 3 3.9 5.1 98 
NO LH NO NO NO NO PROLONGED PROLONGED 18 2 NO 1.1 1 1.6 4.1 68 
NO L NO NO NO NO NO NO NO 1 NO 0.8 2 2.1 2.65 76 
NO L NO NO NO NO NO NO NO 1 NO 1.3 3 3.5 4.9 78 
NO LH NO NO NO NO PROLONGED PROLONGED 26 3 NO 1.9 3 3.6 4.5 67 
NO L NO NO NO NO NO NO NO 1 NO 1.1 3 3.2 5.6 66 
NO LHN NO NO YES NO PROLONGED PROLONGED 18 2 NO 1.1 2 2.3 3.7 88 
NO L NO NO NO NO NO NO NO 1 NO 1.3 3 3.5 4.9 78 
NO L NO NO NO NO NO NO NO 1 NO 1.3 3 3.5 4.9 78 
NO LN NO NO NO NO NO NO NO 1 NO 1.2 3 3.4 4.2 78 
NO LH NO NO NO NO PROLONGED PROLONGED 26 3 NO 1.1 3 3.4 3.4 79 
NO L NO NO NO NO NO NO 24 2 NO 1.1 1 1.6 1.7 67 
NO LHR NO NO NO NO PROLONGED PROLONGED 39 4 NO 3.6 3 3.6 6.1 102 
NO LHR NO NO NO NO PROLONGED PROLONGED 14 2 NO 3.4 3 3.4 5.7 67 
NO LN NO NO NO NO NO NO NO 1 NO 1.1 3 3.1 4.1 76 
NO LN NO NO NO NO NO NO NO 1 NO 0.9 3 4.1 6.4 139 
NO N NO NO YES NO NO NO 19 2 NO 1.1 1 1.6 2.4 101 
NO LH NO NO NO NO PROLONGED PROLONGED 38 4 NO 1.1 3 3.6 5.2 94 
NO L NO NO NO NO NO NO NO 1 NO 1.3 3 3.5 4.9 78 
NO L NO NO NO NO NO NO NO 1 NO 1.1 3 3.5 3.6 96 
NO LH NO NO NO NO PROLONGED PROLONGED 24 2 NO 0.9 3 2.9 3.9 96 
NO LHNR NO NO NO NO PROLONGED PROLONGED 39 4 NO 3.6 3 3.6 6.1 102 
NO LHR SUBNEPH. YES YES YES PROLONGED PROLONGED 20 2 NO 3.1 3 4.1 7.4 66 
NO LHR TRACE YES YES NO PROLONGED PROLONGED 26 3 NO 2.5 3 3.9 4.9 77 
NO HR NO NO NO NO PROLONGED PROLONGED 18 2 NO 2.3 3 3.4 4.4 102 
NO L NO NO NO NO NO NO NO 1 NO 1.3 2 2.9 4.8 69 
NO LR NO NO NO NO NO NO NO 1 NO 2.7 3 5.9 8.9 102 
NO LHR NO NO NO NO PROLONGED PROLONGED 39 4 NO 3.6 3 3.6 5.5 76 
ANURIC HR SUBNEPH. YES YES YES PROLONGED PROLONGED 18 2 YES 3.1 3 4.7 10 81 
NO LHR NO NO NO NO PROLONGED PROLONGED 32 3 NO 2.4 3 4.5 5.1 83 
NO LHR NO NO YES NO PROLONGED PROLONGED 24 2 YES 5.7 3 5.7 5.7 89 
NO N NO NO NO NO NO NO 34 3 NO 0.7 2 1.5 1.8 81 
NO LR NO NO NO NO NO NO 18 2 NO 2.1 3 3.4 4.9 78 
ANURIC LHR TRACE YES YES YES PROLONGED PROLONGED 26 3 YES 3.1 3 3.9 9.2 94 
NO L NO NO NO NO NO NO NO 1 NO 1.1 3 3.2 5.9 66 
NO LHR NO NO NO NO PROLONGED PROLONGED 34 3 NO 1.4 3 3.6 5.1 83 
NO LHR TRACE YES YES NO PROLONGED PROLONGED 34 3 NO   3   6   
NO L SUBNEPH. NO NO NO NO NO 19 2 NO 1.3 3 4.2 6.9 66 
NO L NO NO NO NO NO NO NO 1 NO 1.2 3 3 4.5 84 
NO LH NO NO NO NO PROLONGED PROLONGED 21 2 NO 5 3 5.3 5.3 99 
NO LHN NO NO NO NO PROLONGED PROLONGED 27 3 NO 4.6 3 4.6 4.6 66 
NO LHR NO NO NO NO PROLONGED PROLONGED 28 3 NO 5.4 3 6.9 6.9 112 
 
 K AT  
PTESENTATION 2ND 
HYPERCAT 
ABOLIC 
URINE 
MYO BILURUBIN PEAK LDH CPK PEAK 
DIC WORK 
 UP 
RF  
TIME 
rf 
TIME DIALSIS 
HD/P
D 
DIA. 
TIME SR.CR ASV OUTPUT INDICATION 
4.5 3.9 NO NA N NA N N N 48 3 YES HD 3RD 3.4 18 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
3.9 4.9 YES NA N N N N N 18 1 YES HD 1ST 4.5 23 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
4.7 4.4 NO NA N NA NA N N 27 2 NO NO NA NA 18 NA NA 
4.1 4 NO NA N NA NA N N 54 3 NO NO NA NA 18 NA NA 
4.9 5.7 YES N N NA 284 465 YES 22 1 YES HD 2ND 3.6 23 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
5.2 4.9 NO NA N NA NA 640 NA 28 2 YES HD 2ND 3.1 23 OLIGURIC 
OLIGURIA AND 
RHABDOMYOLYSIS 
4.5 5.6 YES NA N NA NA 322 N 14 1 YES HD 1ST 3.4 13 OLIGURIC 
OLIGURIC AND 
ACIDOSIS 
4.5 4.4 NO NA N NA NA N N 36 2 NO NA NA NA 18 NA NA 
4.4 5.4 YES POSITIVE 4.7 8 534 1340 YES 24 2 YES PD 2ND 9.3 23 ANURIC ANURIA 
4.4 4.2 NO NA N NA NA N N 36 2 YES HD 2ND 3.4 23 OLIGURIC ACIDOSIS 
4.6 3.4 NO NA N NA NA NA N 25 2 NO NA NA NA 18 OLIGURIC NA 
4.9 4.4 NO NA N NA NA N N 15 1 YES HD 2ND 3.4 18 OLIGURIC ACIDOSIS 
4.4 5.7 YES N N NA NA N YES 14 1 YES HD 1ST 3.9 5 OLIGURIC ACIDOSIS 
3.8 4.9 YES POSITIVE 6.1 6.1 440 3400 YES 15 1 YES HD 1ST 6.7 5 ANURIC ANURIC 
4.9 5.9 YES NA N NA NA 433 N 24 2 YES HD 2ND 6.6 23 OLIGURIC ACIDOSIS 
3.4 4.3 NO NA N NA NA N N 20 1 YES HD 2ND 3.2 18 OLIGURIC OLIGURIA 
3.4 3.9 NO NA N NA NA NA N 44 2 NO NA NA NA 18 NA NA 
3.5 NA NO NA N NA NA NA N 52 3 NO NO NA NA 18 NA NA 
NA NA NO NA N NA NA N N 210 8 YES PD 14TH 3.1 23 ANURIC ANURIC 
4.7 5.9 YES POSITIVE 2.4 5.6 731 2389 YES 40 2 YES HD 2ND 3.9 23 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
4.6 4.3 NO NA N NA NA N N 24 2 YES HD 2ND 3.2 23 OLIGURIC ACIDOSIS 
3.4 5.1 YES NA N NA 365 NA YES 29 2 YES HD 2ND 3.4 18 OLIGURIC OLIGURIA 
3.5 3.4 NO NA N NA NA N N 34 2 YES HD 3RD 3.9 23 OLIGURIC ACIDOSIS 
4.1 NA   NA N NA NA NA N 66 3 NO NO NA NA 18 NA NA 
3.8 NA   NA N NA NA NA N 16 1 NO NO NA NA 18 NA NA 
5.1 5.4 YES NA 3.2 3.2 334 340 YES 16 1 YES HD 1ST 3.4 23 OLIGURIC OLIGRIC 
4.3 5.1 YES POSITIVE N NA 423 894 N 18 1 YES HD 2ND 5.1 18 OLIGURIC 
OLIGURIA AND 
RHABDOMYOLYSIS 
3.4 4.9 NN NA N NA NA NA N 44 2 YES HD 2ND 4.1 18 OLIGURIC ACIDOSIS 
4.9 4.4 NO NA N NA NA N N 15 1 YES HD 2ND 3.4 18 OLIGURIC ACIDOSIS 
3.4 4.3 NO NA N NA NA NA N 20 1 YES HD 2ND 3.2 18 OLIGURIC OLIGURIA 
4.3 5.1 YES YES N NA 406 2089 N 32 2 YES HD 2ND 3 18 0LIGURIA RHABDOMYOLYSIS 
4.2 5.6 YES POSITIVE 2.3 2.9 237 673 YES 22 1 YES HD 2ND 4.1 18 ANURIC 
OLIGURIA AND 
ACIDOSIS 
3.4 4.9 NO NA N NA NA NA N 44 2 YES HD 2ND 4.1 18 OLIGURIC ACIDOSIS 
3.4 3.6 NO NA N NA NA NA N 22 1 NO NO NA NA 18 NA NA 
3.4 3.9 NO NA N NA NA NA N 30 2 YES HD 3RD 3.9 18 OLIGURIC OLIGURIA 
3.5 4.1 NO NA N NA NA N N 54 3 NO NA NA NA 18 NA NA 
4.4 5.7 YES NA 2.4 5.6 556 340 YES 24 1 YES HD 1ST 3.4 18 OLIGURIC ACIDOSIS 
3.4 5.1 YES NA 3.1 4.2 766 432 YES 20 1 YES HD 2ND 7.6 23 OLIGURIC OLIGURIA 
3.4 3.8 NO NA N NA NA N N 56 3 NO NO NA NA 18 NA NA 
3.6 3.9 NO NA N NA NA N N 47 2 NO NO NA NA 18 NA NA 
5.2 4.5 NO NA N NA 367 748 N 24 2 YES HD 3RD 3.1 18 NONOLIGURIC HYPERKALEMIA 
4.1 5.1 YES NA N NA NA N N 26 2 YES HD 2ND 3.9 18 OLIGURIC ACIDOSIS 
3.7 4.9 YES NA N NA NA N N 27 2 YES HD 2nd 4.1 18 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
4.1 3.4 NO NA N NA NA NA N 37 2 NO NA NA NA 18 NA NA 
3.4 4.9 NO NA N NA NA NA N 44 2 YES HD 2ND 4.1 18 OLIGURIC ACIDOSIS 
3.4 4.6 YES NA N NA NA N N 28 2 YES HD 2ND 3.6 18 OLIGURIC OLIGURIA 
3.4 4.3 NO NA N NA NA NA N 20 1 YES HD 2ND 3.2 18 OLIGURIC OLIGURIA 
3.7 4.4 NO NA N NA NA N N 34 2 YES HD 3RD 3.7 18 OLIGURIC OLIGURIA 
3.4 4.9 NO NA N NA NA NA N 44 2 YES HD 2ND 4.1 18 OLIGURIC ACIDOSIS 
3.4 4.9 YES NA N NA NA NA N 44 2 YES HD 2ND 4.1 18 OLIGURIC ACIDOSIS 
43 4.4 NO NA N NA NA N N 36 2 YES HD 2ND 3.4 23 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
3.5 3.4 NO NA N NA NA N N 23 1 YES HD 3RD 3.4 18 OLIGURIC OLIGURIA 
3.6 3.4 NO NA N NA NA N N 70 3 NO NO NA NA 18 NA NA 
4.9 5.7 NO NA N NA NA N N 22 1 YES HD 2ND 3.6 23 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
5.1 5.6 YES NA N NA NA 322 N 14 1 YES HD 1ST 3.4 13 OLIGURIC 
OLIGURIC AND 
ACIDOSIS 
4.9 3.2 NO NA N NA NA 360 N 28 2 YES HD 2ND 3.1 23 OLIGURIC OLIGRIC 
5.3 5.1 NO NA N NA NA NA N 412 14 YES PD 16TH 4.1 23 ANURIC ANURIC 
3.5 NA NO NA N NA NA NA N 56 2 NO NO NA NA 18 NA NA 
4.7 4.4 NO NA N NA NA N N 38 2 YES HD 3RD 5.4 18 OLIGURIC ACIDOSIS 
3.4 4.9 NO NA N NA NA NA N 44 2 YES HD 2ND 4.1 18 OLIGURIC ACIDOSIS 
3.4 4.6 NO NA N NA NA NA N 44 2 YES HD 2ND 4.1 18 OLIGURIC ACIDOSIS 
3.8 3.1 NO NA N NA NA N N 22 1 YES HD 3RD 2.9 18 OLIGURIC OLIGURIA 
4.5 5.7 YES NA N NA NA N N 22 1 YES HD 2ND 3.6 23 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
3.6 5.1 YES NA N NA NA N N 14 1 YES HD 2ND 3.9 23 OLIGURIC ANURIC 
5.4 5.7 NO NA N NA 344 N YES 14 1 YES HD 1ST 3.9 5 OLIGURIC ACIDOSIS 
4.9 4.4 NO NA N NA NA N N 15 1 YES HD 2ND 3.4 18 OLIGURIC ACIDOSIS 
3.5 4.6 NO NA N NA NA NA N 48 3 YES HD 3RD 3.2 18 OLIGURIC ACIDOSIS 
5.1 5.9 YES POSITIVE N NA 432 986 N 36 2 YES HD 2ND 5.9 18 OLIGURIC RHABDOMYOLYSIS 
4.9 5.7 NO NA N NA NA N N 22 1 YES HD 2ND 3.6 18 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
4.1 5.6 YES POSITIVE 3.2 4.4 451 874 YES 22 1 YES HD 2ND 4.1 18 ANURIC 
OLIGURIA AND 
ACIDOSIS 
3.4 4.7 NO NA N NA N N N 33 2 YES HD 3RD 4.5 18 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
3.4 3.6 NO NA N NA NA NA YES 72 4 YES HD 3RD 5.9 18 OLIGURIC 
OLIGURIC AND 
ACIDOSIS 
3.4 3.3 NO NA N NA NA N N 34 2 NO NO NA NA 18 NA NA 
3.6 4.5 NO NA N NA NA NA N 22 1 YES HD 2ND 3.4 18 
NONOLIGURI
C ACIDOSIS 
4.1 5.2 YES NA 2.6 3.2 379 1095 YES 18 1 YES HD 2ND 5.1 23 OLIGURIC OLIGURIA 
3.4 4.3 NO NA N NA NA NA N 20 1 YES HD 2ND 3.2 18 OLIGURIC OLIGURIA 
3.4 4.7 YES NA N NA N N N 34 2 YES HD 3RD 3.6 18 OLIGURIC 
OLIGURIA AND 
ACIDOSIS 
    YES NA         NO     YES HD     18     
4.1 4.4 NO NA N NA NA N N 16 1 YES HD 2ND 4.2 18 OLIGURIC OLIGURIA 
4.3 3.9 NO NA N NA NA NA N 32 2 YES HD 2ND 4.4 18 0LIGURIA RHABDOMYOLYSIS 
3.9 5.2 NO NO N NA NA N N 24 2 YES HD 2ND 5.3 23 OLIGURIC 
OLIGRIA AND 
ACIDOSIS 
34 4.5 NO NO N NA NA N N 22 1 YES HD 2ND 4.6 23 OLIGURIC ACIDOSIS 
3.4 4.5 NO NO N NA NA N N 23 1 YES HD 2ND 4.5 23 OLIGURIC ACIDOSIS 
 
TOTAL DURATION 
IMPR.O
UTPUT 
BASELI
NE BIOPSY OUTCOME 
CAUSE OF 
DEATH 
TIME OF 
DEATH 
VENTIL
ATOR 
POST 
CARDIAC  
ARREST MEDICAL DIS .CR 
FOLLOW UP  
EGFR LATEST 
4 SESSIONS 8DAYS 9 DAYS 13 NOTDONE RECOVERED NA NA NO NO NA 1 N NA 
3 4 NA NA NOTDONE EXPIRED SEPSIS 5TH YES YES SEPSIS NA EXPIRED EXPIRED 
NA NA NA 6 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
NA NA NA 6 NOTDONE RECOVERED NA NA NO NO NA 0.9 N NA 
8 17 16 28 ATN RECOVERED NA NA NO NO NA 1.8 82 82 
4 8 5 8 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
5 9 5 17 NOTDONE 
PARTIAL 
RECOVERY NA NA NO NO NA 1.7 78 72 
NA NA NA NA NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
PD 2 NA NA NOTDONE EXPIRED DIC SEPSIS 3 DAYS YES NO 
DIC 
SEPSIS NA EXPIRED EXPIRED 
4 9 7 16 NOTDONE RECOVERED NA NA NO NO NA 1.2 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NO NO NA 0.9 N NA 
3 6 4 9 NOTDONE RECOVERED NA NA NO NO NA 1.3 N NA 
8 19 
OLIGUR
IC NA CAN 
PARTIAL 
RECOVERY NA NA NO NO NA 2.1 74 86 
1 1 NA NO NOTDONE EXPIRED DIC 1 DAY YES YES 
DIC 
SEPSIS EXPIRED EXPIRED EXPIRED 
9 17 14 NA ATN 
PARTIAL 
RECOVERY NA NA NO NO NA 2.9 25 25 
5 8 6 13 NOTDONE RECOVERED NA NA NO NO NA 1.2 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NO NO NA 1.2 N NA 
PD 2 NA NA NOTDONE EXPIRED VAP 21DAYS YES YES SEPSIS   EXPIRED EXPIRED 
2 2 NA NO NOTDONE EXPIRED 
DIC AND  
RHABDOM
YOLYSIS   NO NO NA EXPIRED EXPIRED EXPIRED 
6 11 8 15 NOTDONE NA NA NA NO NO NA 1.1 N NA 
11 21 15 33 ATN RECOVERED NA NA NA NA NA 1.2 N NA 
4   7 11 NOTDONE NA NA NA NO NO NA 0.9 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NA NA NA 1.1 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NA NA NA 1.2 N NA 
5 8 NA NA NOTDONE EXPIRED SEPSIS 9TH YES YES 
DIC 
SEPSIS NA EXPIRED EXPIRED 
5 11 8 17 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
4 7 6 11 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
4 6 4 9 NOTDONE RECOVERED NA NA NO NO NA 1.3 N NA 
4 8 6 13 NOTDONE RECOVERED NA NA NO NO NA 1.2 N NA 
11 26 21 34 CAN 
PARTIAL 
RECOVERY NA NA NA NA NA 2.1 68 60 
9 21 16 NO ATN PARTIAL NA NA NA NA NA 1.8 2.1 76 
4 7 6 11 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NA NA NA 0.9 N NA 
4 6 5 11 NOTDONE RECOVERED NA NA NO NO NA 1 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NO NO NA 1.2 N NA 
11 26 
OLIGUR
IC NO CAN 
PARTIAL 
RECOVERY NA NA NO NO NA 2.6 56 45 
EXPIRED EXPIRED 
EXPIRE
D 
EXPIR
ED TMA EXPIRED SEPSIS 25 YES NO SEPSIS EXPIRED EXPIRED EXPIRED 
NA NA NA NA NOTDONE RECOVERED NA NA NA NA NA 1.1 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NA NA NA 1.1 N NA 
3 6 
NONOLI
GURIC 9 NOTDONE RECOVERED NA NA NA NA NA 1.2 N N 
8 16 11 19 ATIN 
PARTIAL 
RECOVERY NA NA NA NA NA 1.6 56 56 
4 6 5 9 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
NA NA NA NA NOTDONE RECOVERED   NA NO NO NA 0.9 N NA 
4 7 6 11 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
4 6 7 NA NOTDONE RECOVERED NA NA NA NA NA 1.1 N NA 
5 8 6 13 NOTDONE RECOVERED NA NA NO NO NA 1 N NA 
4 7 8 12 NOTDONE RECOVERED NA NA NO NO NA 0.9 N NA 
4 7 6 11 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
4 7 6 11 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
ON MHD ON MHD 
OLIGUR
IC MHD ATN 
NO 
RECOVERY NA NA NA NA NA 4.3 ON MHD 24 
3 SESSIONS 5DAYS 4DAYS 9 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NO NO NA 1.2 N NA 
8 19 18 28 ATN RECOVERED NA NA NA NA NA 1.8 82 82 
5 9 5 NO NOTDONE 
PARTIAL 
RECOVRY NA NA NO NO NA 1.7 82 72 
3 5 4 9 NOTDONE NA NA NA NA NA NA 1 N NA 
PD 2 NA NA NOTDONE EXPIRED VAP 9 DAYS YES YES NA NA EXPIRED EXPIRED 
NA NA NA NA NOTDONE RECOVERED NA NA NA NA NA 1.1 N NA 
4 7 8 10 NOTDONE RECOVERED NA NA NO NO NA 1.2 N NA 
4 7 6 11 NOTDONE RECOVERED NA NA NO NO NA 1.1 N NA 
5 9 7 13 NOTDONE RECOVERED NA NA NO NO NA 0.9 N NA 
4 SESSIONS 8DAYS 7TH 11 NOTDONE RECOVERED NA NA NO NO NA 1.3 N NA 
10 17 14 NO ATN 
PARTIAL 
RECOVERY NA NA NA NA NA 1.9 72 EXPIRED 
6 11 8 21 NOTDONE RECOVERED NA NA NA NA NA 1.3 N NA 
4 8 7 12 NOTDONE RECOVERED NA NA NA NA NA 1.1 N NA 
4 6 4 9 NOTDONE RECOVERED NA NA NO NO NA 1.3 N NA 
5 8 7 15 NOTDONE RECOVERED NA NA 
RECOV
ERED NA NA 1.4 N NA 
8 17 19 26 ATN PARTIAL NA NA NA NA NA 1.4 78 78 
5 9 10 16 NOTDONE RECOVERED NA NA NA NA NA 1.1 N NA 
12 24 15 NO 
CAN DONE  
OUTSIDE 
PARTIAL 
RECOVERY NA NA NA NA NA 2.4 2.1 66 
5 9 9 DAYS 
14 
DAYS NOTDONE RECOVERED NA NA NO NO NA 1.4 N NA 
2 DEATH DEATH DEATH NOTDONE EXPIRED DIC 5 YES YES SEPSIS DEATH N NA 
NA NA NA NA NOTDONE RECOVERED NA NA NA NA NA 1.4 NA NA 
11 22 NO NO ATIN EXPIRED CRBSI 22 NO NO NO EXPIRED EXPIRED EXPIRED 
12 26 
OLIGUR
IC NO TMA PARTIAL NA NA NO NA NA 5.4 25 ON MHD 
6 11 6 16 NOTDONE RECOVERED NA NA NO NO NA 1.2 N NA 
7 16 13 21 NOTDONE RECOVERED NA NA NO NO NA 1.4 N NA 
        CAN 
PARTIAL 
RECOVERY NA NA NA NA NA 5.6 ON MHD MHD 
9 21 16 32 ATIN NA NA NA NA NA NA 1.1 1.1 NA 
6 11 8 11 NOTDONE RECOVERED NA NA NA NA NA N NA NA 
5 7 8 13 NOTDONE NA NA NA NA NA NA 1.3 1.1 NA 
4 15 17 21 ATN RECOVERED NA NA NA NA NA 1.1 1.1 NA 
7 17 15 21 ATN RECOVERED NA NA NA NA NA 1.1 1.1 NA 
 
 
NAME  
AG
E 
AG
E 
SE
X 
EDUCAT
ION 
SOCIO 
ECONO
MIC 
AMOU
NT ALCOHOL KNOWN 
TIME 
LAG  
TO  
DIAGN
OSIS 
IST 
 
SPO
T 
TIME  
CONSU
MED 
TREATMENT AT IST 
SPOT 
REFERAL  
TO 
DIALYS 
TOTAL 
 LAG LAG 
PREUM
PTIVE  
HD 
PRESENTATIO
N HB 
MUTHU 45 4 2 1 1 4 ALCOHOLIC NO 4 1 4 
EARLY 
DECONTAMINATION 
INDIREC
T 48 3 NO 
COMATOSE, 
SEIZURES 11.2 
MANIKAND
AN 32 3 2 1 1 3 ALCOHOLIC YES 4 1 2 
EARLY 
DECONTAMINATION DIRECT 9 1 YES SEIZURE 10.4 
KATHIRVEL 28 2 2 1 1 4 ALCOHOLIC YES 1 2 8 
EARLY 
DECONTAMINATION DIRECT 11 1 YES SEIZURE 11.9 
SATHYA 28 2 1 2 2 3 NON 
NOTKNO
WN 6 1 2 
EARLY 
DECONTAMINATION DIRECT 28 2 NO 
COMATOSE, 
SEIZURES 7.1 
MANICKA
M 30 3 2 1 2 3 NON YES 1 1 2 
EARLY 
DECONTAMINATION 
INDIREC
T 6 1 YES GI 10 
MARAGAT
HAM 26 2 1 3 1 2 
NONALCOH
OLIC KNOWN 1 2 44 
DECONT,AND 
SUPPORTIVE DIRECT 46 3 NO RENAL 8.1 
KALAIARASI 39 3 1 2 1 4 NON YES 1 2 4 
EARLY 
DECONTAMINATION DIRECT 10 1 YES GI 9.4 
DHAYALAN 46 4 2 3 2 4 ALCOHOLIC YES 2 1 4 
EARLY 
DECONTAMINATION DIRECT 8 1 YES GI 9.3 
KUMAR 36 3 2 1 2 1 
NONALCOH
OLIC 
NOTKNO
WN 1 2 36 
DECONTAMINATION 
AND  
SUPPORTIVE DIRECT 40 2 NO GI,RENAL 10.3 
KESAVAN 50 5 2 1 1 2 
NONALCOH
OLIC KNOWN 2 3 1 
EARLY 
DECONTAMINATION DIRECT 8 1 YES GI 9.3 
MUTHU 25 2 2 2 2 3 ALCOHOLIC 
NOTKNO
WN 2 2 4 
EARLY 
DECONTAMINATION DIRECT 24 1 NO GI 10.1 
THIRMALAI 40 4 2 1 2 2 
NONALCOH
OLIC 
NOTKNO
WN 3 2 12 
DECONT,AND 
SUPPORTIVE DIRECT 48 3 NO GI,RENAL 8.9 
BALAJI 18 1 2 1 1 2 ALCOHOLIC 
N0TKNO
WN 6 1 2 
EARLY 
DECONTAMINATION DIRECT 28 2 NO 
COMATOSE, 
SEIZURES 9.9 
VELU 25 2 2 1 1 2 ALCOHOLIC KNOWN 2 1 2 
EARLY 
DECONTAMINATION DIRECT 9 1 YES SEIZURE 10.4 
MURALI 21 2 2 3 2 2 ALCOHOLIC 
NOTKNO
WN 4 2 48 
DECONT,AND 
SUPPORTIVE DIRECT 56 3 NO RENAL 8.4 
ASHOK 25 2 2 1 1 3 ALCOHOLIC 
NOTKNO
WN 2 2 4 
EARLY 
DECONTAMINATION DIRECT 30 2 NO GI 11.4 
VIMALA 29 2 1 2 1 2 
NONALCOH
OLIC 
NOTKNO
WN 4 2 36 
DECONT,AND 
SUPPORTIVE DIRECT 46 3 NO RENAL 7.9 
NAGARA 23 2 2 1 2 2 
NONALCOH
OLIC KNOWN 1 2 72 
DECONT,AND 
SUPPORTIVE DIRECT 76 4 NO RENAL 11.3 
RAJEEV 
GANDHI 23 2 2 3 1 2 
NONALCOH
OLIC KNOWN 1 2 79 
DECONT,AND 
SUPPORTIVE DIRECT 85 4 NO RENAL 11 
ARULRAJ 20 2 2 3 1 2 ALCOHOLIC 
NOTKNO
WN 4 2 88 
DECONT,AND 
SUPPORTIVE DIRECT 96 4 NO RENAL 10.1 
VARADARA
JAN 36 3 2 3 1 2 ALCOHOLIC 
NOTKNO
WN 4 3 12 
DECONTAMINATION 
AND  
SUPPORTIVE DIRECT 14 1 YES GI 11 
VIJAYAKU
MR 22 2 2 1 1 3 ALCOHOLIC YES 1 2 44 
DECONT,AND 
SUPPORTIVE DIRECT 46 3 NO RENAL 8.1 
AMULRAJ 20 2 2 1 1 3 
NONALCOH
OLIC YES 1 2 4 
EARLY 
DECONTAMINATION DIRECT 10 1 YES GI 9.4 
RAMESH 30 3 2 1 1 4 ALCOHOLIC YES 2 1 4 
EARLY 
DECONTAMINATION DIRECT 8 1 YES GI 9.3 
JAMUNA 17 1 1 1 1 4 
NONALCOH
OLIC YES 1 2 36 
DECONTAMINATION  
AND SUPPORTIVE DIRECT 40 2 NO GI,RENAL 10.3 
 
 
 
 
PULMONARY 
SPO2/ 
PAO2 P R ARDS PULSE BP VENTILATOR 
CARDIAC 
ARREST HEPATIC CNS O.P C.P B.P TIME OF RF 
YES <200 <200 YES STERIOD HYPOTENSION YES YES NO YES ANURIC 4.9 96 48 hrs 
NO <500 <500 NO NO N NO NO NO YES NONOLIGURIC 1.1 33 72 
YES <200 <200 YES STERIOD N YES NO NO YES NONOLIGURIC 1.1 49 54 
NO <500 <500 NO NO N NO NO NO YES OLIGURIC 1.6 45 28 
YES <500 <200 YES NO N YES NO NO NO NONOLIGURIC 0.9 39 74 
YES <500 <500 NO NO N NO NO MILD NO OLIGURIC 2.3 88 AT PRESEN 
YES <500 <200 YES STERIOD N YES NO YES NO NONOLIGURIC 1 39 18 
YES <500 <200 YES STERIOD N YES NO YES NO NONOLIGURIC 1.1 64 34 
YES >500 >500 NO NO N NO NO NO NO NONOLIGURIC 2.9 74 38 
YES <500 <200 YES NO HYPOTENSION YES NO YES YES OLIGURIC 1.3 66 36 
YES <200 <200 YES NO N YES NO YES NO OLIGURIC 2.2 66 AT PRESEN 
YES <500 <500 NO NO N NO NO MILD NO OLIGURIC 1.4 77 48 
NO <500 <500 NO NO N NO NO NO YES OLIGURIC 1.8 66 AT PRESEN 
NO <500 <500 NO NO N NO NO NO YES NONOLIGURIC 1.1 33 72 
YES <500 <500 NO NO N NO NO NO NO OLIGURIC 2.4 68 AT PRESEN 
YES <200 <200 YES NO HYPOTENSION YES YES YES NO OLIGURIC 1.9 59 AT PRESEN 
YES <500 <500 NO NO N NO NO NO NO NONOLIGURIC 2.1 68 AT PRESEN 
YES <500 <200 YES NO N YES NO MILD NO OLIGURIC 3.2 88 AT PRESEN 
YES <500 <200 YES STERIOD N YES NO NO NO OLIGURIC 3.3 112 AT PRESEN 
YES <500 <200 YES STERIOD N NO NO NO NO OLIGURIC 21 134 AT PRESEN 
YES <200 <20 YES NO HYPOTENSION YES YES YES YES ANURIC 1.1 66 16 
YES <500 <500 NO NO N NO NO MILD NO OLIGURIC 2.3 88 AT PRESEN 
YES <500 <200 YES STERIOD N YES NO YES NO NONOLIGURIC 1 39 18 
YES <500 <200 YES STERIOD N YES NO YES NO NONOLIGURIC 1.1 64 34 
YES >500 >500 NO NO N NO NO NO NO NONOLIGURIC 2.9 74 38 
 O.R C.R B.R 
INDICATION 
FOR HD 
TOTAL 
SESSION DURATION OUTCOME 
OUTPUT 
IMPROVED C.B CAUSE OF DEATH TIME C.D C.F LONG TERM 
NA NA NA ANURIC PD NA DEATH DEATH NA ARDS 3 DEATH DEATH DEATH 
NONOLIGURI 2.1 66 NA 4 6 RECOVERED 
NONOLIGUR
IC 7 NA NA 0.9 NA NA 
OLIGURIC 3.3 98 ACIDOSIS 4 6 DEATH DEATH NA ARDS 7 DEATH DEATH DEATH 
OLIGURIC NA NA ACIDOSIS 6 9 EXPIRED 8 13 NA NA 1.1 NA NA 
NONOLIGURI 1.7 69 NA 3 5 RECOVERED 
NONOLIGUI
C 8 NA NA 0.8 NA NA 
NONOLIGURIC NA NA NA 3 5 RECOVERED 4 7 NA NA 1 NA NA 
ANURIC 2.4 85 ANURIC 2 2 DEATH DEATH NA ARDS 3 DEATH DEATH DEATH 
OLIGURIC 3.1 97 ACIDOSIS 1 7 DEATH NA NA ARDS 9 DEATH DEATH DEATH 
NONOLIGURI 2.9 74 ACIDOSIS 2 2 RECOVERED 
NONOLIGUR
IC 6 NA NA 1.1 NA NA 
OLIGURIC 3.2 132 ACIDOSIS PD NA DEATH DEATH NA 
ARDS,CARDIOGE
NIC SHOCK 3 DEATH DEATH DEATH 
OLIGURIC NA NA ACIDOSIS 5 8 DEATH DEATH NA ARDS 9 DEATH DEATH DEATH 
OLIGURIC 2.7 88 ACIDOSIS 5 10 RECOVERED 7 11 NA NA 1 N NA 
OLIGURIC NA NA ACIDOSIS 6 9 RECOVERED 6 11 NA NA 1 NA NA 
NONOLIGURI 2.1 66 NA 4 6 RECOVERED 
NONOLIGUR
IC 7 NA NA 0.9 NA NA 
OLIGURIC NA NA NA 4 6 RECOVERED 4 6 NA NA 1.2 NA NA 
ANURIC NA NA ANURIA PD NA DEATH DEATH NA 
CARDIOGENIC 
SHOCK,ARDS 3 DEATH DEATH DEATH 
NONOLIGURIC NA NA NA 2 4 RECOVERED 6 NA NA 0.9 NA NA 
OLIGURIC NA NA NA 6 9 RECOVERED 8 11 NA NA 1.2 NA NA 
OLIGURIC NA NA NA 4 6 RECOVERED 9 11 NA NA 1.1 NA NA 
ANURIC NA NA ACIDOSIS 2 3 DEATH DEATH NA ARDS 5 DEATH DEATH DEATH 
ANURIC 1.9 99 ACIDOSIS 2 4 DEATH DEATH NA ARDS 5 DEATH DEATH DEATH 
NONOLIGURIC NA NA NA 3 5 DEATH DEATH NA ARDS 3 1 NA NA 
ANURIC 2.4 85 ANURIC 2 2 DEATH DEATH NA ARDS 3 DEATH DEATH DEATH 
OLIGURIC 3.1 97 ACIDOSIS NA NA DEATH NA NA ARDS 1 DEATH DEATH DEATH 
NONOLIGURI 2.9 74 ACIDOSIS NA NA DEATH DEATH NA ARDS 1 1.1 NA NA 
 
 
 NAME  
AG
E 
SE
X 
EDUCAT
ION 
SOCIOECON
OMIC 
OCCUPAT
ION 
PLA
CE 
NATI
VE 
SPECIE
S 
Ist 
CARE 
STIN
GS  
REMO
VED 
REFERAL 
LAG BP OUTPUT 
PROTIEN
URIA 
HEMAT
RIA HB 
YUGIN 21 M 1 1 ACCIDENTAL NO 
VESPE
DIA 60 24 YES 6 HRS HIGH OLIGURIC YES YES 
11.
1 
SIVASHANK
AR 70 M 1 1 ACCIDENTAL NO 
VESPE
DIA 40 30 YES 12 HRS N 
NON 
OLIGURIC NO NO 9.7 
ravi 40 M 2 1 OCCUPATIONAL NO 
VESPE
DIA 34 72 YES 7 HRS HIGH OLIGURIC NO YES 
10.
3 
MOORTHI 38 M 2 1 OCCUPATIONAL NO 
VESPE
DIA 20 42 YES 2HRS N OLIGURIC NO NO 
11.
8 
MANAVAL
AN 85 M 1 1 ACCIDENTAL NO 
VESPE
DIA 40 48 YES 11HRS N 
NON 
OLIGURIC NO YES 8.4 
SETTU 25 M 1 1 ACCIDENTAL 
TOPIC
AL 
VESPE
DIA 60 12 YES 24HRS N OLIGURIC YES NO 8.9 
LAKSMI 27 F 3 2 ACCIDENTAL NO 
VESPE
DIA 60 31 YES 4HRS N 
NON 
OLIGURIC YES NO 8.1 
KANDASW
AMY 36 F 2 2 OCCUPATIONAL NO 
ASPED
IA 90 NO NO 2HRS 
HYPOTEN
SION OLIGURIC NO NO 
11.
1 
DINESHKU
MAR 22 M 1 1 OCCUPATIONAL NO 
VESPE
DIA 60 45 YES 2HRS N 
NON 
OLIGURIC NO NO 12 
CHINNASW
AMY 35 M 1 2 OCCUPATIONAL NO 
VESPE
DIA 60 43 YES 4HRS N 
NON 
OLIGURIC NO NO 11 
DHANAPAL
73 73 M 1 2 ACCIDENTAL 
TOPIC
AL 
VESPE
DIA 34 34 
PARTIA
L 7HRS 
HYPOTEN
SION OLIGURIC NO NO 11 
 
 PLAS
MA 
HB 
RETIC
ONT LDH CPK 
SR.BI
LRUB
IN OT PT 
PLATE
LET PT 
APT
T DIC SR.K 
ANA
PHYL
AXIS 
ANGIOE
DEMA SHOCK 
UTRC
ARIA LIVER 
COAGU
LOPATH
Y 
RHABD
OMYOL
YSIS 
RESPIR
ATORY 
BL.UR
EA 
II 
UREA 
NO NO 123 549 0.8 24 14 2.8 NO NO NO 3.7 NO NO 
NEUROG
ENIC YES NO NO YES ARDS 112 145 
NO NO 128 36 0.9 22 12 2.6 NO NO NO 3.2 YES NO NO YES NO NO NO NO 96 143 
NO NO 728 
132
8 0.8 28 32 2.4 NO NO NO 5.8 NO NO 
NEUROG
ENIC YES NO NO YES NO 88 144 
NO NO 108 650 0.8 20 14 2 NO NO NO 4 NO NO NO YES NO NO YES NO 94 132 
NO NO 340 983 1 28 22 2.8 NO NO NO 5.6 NO NO NO YES NO NO YES NO 89 96 
YES 
ELEV
ATED 670 
322
0 2.1 34 23 0.8 
PROLO
NGED 
PRO
LON
GED YES 5.2 NO NO NO YES YES YES YES NO 112 156 
NO NO 453 978 0.9 34 16 1.1 NO NO NO 3.9 NO NO NO YES NO NO YES NO 78 92 
NO NO 344 588 0.8 23 12 1.3 NO NO NO 4.6 NO NO 
CARDIOG
ENIC YES NO NO YES NO 110 154 
NO NO 440 877 1.3 23 22 1.1 NO NO NO 5.2 NO NO NO NO NO NO YES NO 59 72 
NO NO 345 874 1.1 24 24 1.6 NO NO NO 4.9 NO NO NO NO NO NO YES NO 55 66 
YES YES 567 
344
4 2.5 65 77 1.8 
PROLO
NGED 
PRO
LON
GED YES 5.4 YES YES YES YES YES YES YES YES 145 188 
 
 
 FA
D 
HD
/P
D 
DIA
.TI
ME 
SR.
CR 
P SR.CR 
OUT
PUT 
INDIC
ATION TOTAL 
DURATI
ON 
BIOPS
Y 
STE
RIO
DS 
RESP
ONSE 
IMPR.O
UTPUT 
BAS
ELIN
E 
DE
AT
H 
CAUSE 
OF 
DEATH 
TIME OF 
DEATH 
VENTI
LATOR 
DIS 
.CR 
FOLLOW 
UP EGFR LATEST 
speci
al 
ste
rio
d 
resp
onse 
NO HD 1ST 13 13 
OLIG
URIC 
RHAB
DO 5 11 
NOTD
ONE NO NA 6 13 NA NA NA NA 1.1 1.1 N NO NO NO 
YES HD IST 7.6 7.6 
OLIG
URIC 
ACID
OSIS 10 22 AIN YES 
GOO
D 20 24 NA NA NA NA 1.7 0.6 N NO yes 
goo
d 
YES HD IST 8.7 8.7 
OLIG
URIC 
RHAB
DO 14 20 
NOTD
ONE NO NA 21 24 NA NA NA NA 1.4 0.9 N 
myo
glob
u NO NO 
YES HD IST 8.4 8.4 
OLIG
URIC 
RHAB
DO 5 9 ATN NO NA 11 14 NA NA NA NA 1.1 0.9 N NO NO NO 
YES HD IST 6.9 6.9 
ANU
RIC 
RHAB
DO 18 33 
ATN/A
IN YES 
GOO
D 23 27 NA NA NA NA 1.1 1.1 N NO NO NO 
YES HD 
2N
D 9.6 9.6 
OLIG
URIC 
ACID
OSIS 
NOT 
RECOVE
RED 
NOTREC
OVERED 
ATN/A
IN YES 
GOO
D CKD 
ON 
MH
D YES SEPSIS 
4 
M0ONT
HS NA 4.2 1.2 
lost 
follow 
up NO NO 
defa
ulter 
YES HD IST 5.4 5.4 
OLIG
URIC 
RHAB
DO 11 23 
ATN/A
IN NO 
GOO
D 18 24 NA NA NA NA 2.1 1.1 N NO NO 
goo
d 
YES HD IST 6.3 6.3 
ANU
RIC 
ANUR
IA 6 10 
NOTD
ONE NO NA 8 11 NA NA NA NA 1.6 1.1 N NO NO NO 
YES NO NO 1.7 1.9 
NON
OLIG
URIC 
RHAB
DO NO NO 
NOTD
ONE NO NA NA NA NA NA NA NA 1.1 0.9 N NO NO NO 
YES NO NO 1.9 1.9 
NON
OLIG
URIC 
RHAB
DO NO NO 
NOTD
ONE NO NA NA NA NA NA NA NA 1.2 0.9 N NO NO NO 
NO HD 1ST 6.7 8.3 
ANU
RIC 
RHAB
DO 2 2 
NOTD
ONE NO NA NA NA 
DE
AT
H DIC 2ND YES 
DE
AT
H 1 n 
myo
glob
u NO 
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TOTAL AKI 
0 10 20 30 40 50 60 70 80 90
SNAKE BITE
Scorpion Sting
UNKNOWN BITE
WASP
Corrosives
Cuso4
PARAQUAT
Rodenticide
Pesticide
Plant Poison
Alcohol
Hair Dye
Others
CRAB BILE
 
 
 
SEX DISTRIBUTION 
0
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DIALYSIS  REQUIREMENT 
0
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NON DIALYSIS(M) NON DIALYSIS(F)
 
 
020
40
60
80
100
120
140
160
180
200
OUTCOME
Total cases
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Biopsy
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MORTALITY 
0
20
40
60
80
100
120
140
160
180
TOTAL DEATH
DEATH IN AKI
 
SNAKE BITE AGE DISTRIBUTION 
0 5 10 15 20 25 30
Age  
20-Dec
21-30 
31-40 
41-50 
51-60 
ABOVE 60 
Sales
 
AGE WISE OUTCOME IN SNAKE BITE 
<20
21-30 
31-40 
41-50 
51-60 
ABOVE 60 
2
14
19
25
15
8
2
12
14
20
13
6
0
1
0
3
3
3
CKD DIALYSIS Total 
 
SNAKE BITE  
 
0
5
10
15
20
25
30
35
40
45
50
MALE FEMALE
DIALYSIS REQUIRING
INDEPENDENT
RECOVERED
PARTIAL
DEATH
 
TIMING OF BITE AND OUTCOME 
0
20
40
60
Total Dialysis Death 
4 am -8am 
8am-6pm 
6pm-4 am 
 
SNAKE BITE  
LEVEL OF CARE AND OUTCOME: 
0 20 40 60
Primary 
Secondary 
tertiary 
native 
CKD
Death 
Dialysis 
total 
 
NATIVE MEDICATION AND OUTCOME 
0 50 100
YES 
CKD 
DEATH 
DIALYSIS 
TOTAL 
 
 
69
14
57
1012
4
50
13
9
1
10
0
YES NO
cellulitis
TOTAL DIALYSIS NON RECOVERED PARTIAL DEATH
 
 
SNAKE BITE  
46
3738
29
8 8
34
29
7
35 5
YES NO
LYMPHADENOPATHY
TOTAL DIALYSIS NON RECOVERED PARTIAL DEATH
 
FANG MARKS AND OUTCOME 
0
10
20
30
40
50
60
70
Yes No
Total
Dialysis
Non
Recovered
Partial
Death
 
RENAL FAILURE AT PRESENTATION AND OUTCOME: 
32
7
12 13
0
5
10
15
20
25
30
35
Number of cases death Partial recovery Complete recovery
 
SNAKE BITE  
Russell Sawscaled Pit viper cobra krait unknown
28
9
3
4
0
28
12
6
3
0 0
8
1 0 0
4 4
2
12
7
3
1 0
9
presentation
Local Hematological Neurological Renal
 
SYMPTOM ANALYSIS 
0
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total
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death
 
 
 
 
SNAKE BITE  
LABAROTARY PARAMETERS 
0
5
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Total
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TIME OF NORMALIZATION OF WBCT 
0
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10
15
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Total
Dialysis
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Recovered
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SNAKE BITE  
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PARAQUAT 
11
2
11
3
Male Female
Recovered death
 
 
Amount of poison and Outcome 
0
2
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6
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10
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A <10ml B 10-20ml C20-50 ml D>50 ml
TOTAL
RECOVERED
DEATH
 
 
 
AGE WISE DISTRIBUTION 
0
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Preemptive dialysis and Outcome 
0
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total
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PARAQUAT 
Baseline hemogobulin vs Outcome  
0
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TOTAL
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DEATH
 
 
AMOUNT AND OUTCOME 
0
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INSECTICIDE 
0
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1
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4
4.5
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